Full Report

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Industry in One Page

Aerospace and Defense is a duopoly-plus-oligopoly capital goods industry where almost all the lifetime profit is earned after the product is sold. Two airframers (Airbus, Boeing) decide which narrowbody and widebody jets the world flies; a tiny club of engine OEMs (GE Aerospace, Pratt & Whitney, Rolls-Royce, Safran via the CFM joint venture) and equipment primes (Collins/RTX, Honeywell, Safran, Thales) supply the parts. The original equipment (OE) sale is often a low-margin (sometimes loss-leading) entry ticket. The real profit pool is the aftermarket — spare parts, shop visits, and "power-by-the-hour" service contracts on the installed base of engines and equipment that fly for 25–30 years. Defense layers on top: governments buy hardware on long programs, then pay decades of MRO at regulated margins.

The cycle has three engines that turn at different speeds: airframer production rates (volatile, 3–7 year ramps), global passenger traffic (steady ~4–5% long-term but cyclical), and government defense budgets (slow but currently rising on geopolitics). The newcomer's mistake is treating these companies like industrial cyclicals tied only to new-jet build rates. In reality, the installed base annuity dominates valuation: an engine sold in 2018 still pays into 2045.

Takeaway: Engine OEMs and tier-1 equipment primes capture the bulk of the value because once their part is on the aircraft type certificate, it stays there for 25+ years — the aftermarket is a property right.

How This Industry Makes Money

The revenue model is "razor-and-blades, on a 30-year timeline." Engine and equipment OEMs invest $1–11 billion over 5–10 years to develop a new product, then sell the original equipment to airframers at thin or negative margins to capture the platform. Once the part is certified onto an aircraft type, every spare part, repair, and shop visit for the next 25–30 years flows to the OEM at gross margins that are roughly 2–4× the OE margins. Safran's FY2025 mix illustrates this neatly: Propulsion is 65% services / 35% OE, Equipment & Defense 39% services / 61% OE, Interiors 37% services / 63% OE. The Propulsion mix is what investors pay up for.

Define the key terms once:

• OE (original equipment) — the new product sold to an airframer or government.
• Aftermarket / MRO (maintenance, repair, overhaul) — spare parts and services for the installed base.
• RPFH (rate per flight hour) — a long-term service contract where the airline pays a fixed dollar amount for every hour the engine flies; the OEM bears the risk of unplanned removals in exchange for a recurring annuity.
• Type Certificate — the regulatory document (issued by EASA, FAA, etc.) that names which parts and suppliers are allowed on a given aircraft model. Without it you cannot sell a single part.
• CFM, GTF, Trent — the three narrowbody/widebody engine families (CFM LEAP = Airbus A320neo + Boeing 737 MAX; Pratt GTF = A320neo only; Rolls-Royce Trent = widebody A330neo/A350).
• PBH / SFE / BFE — Power-By-the-Hour service plans; Supplier-Furnished vs Buyer-Furnished Equipment (who picks the part: airframer or airline).

The cost base is R&D + labor + materials + amortized program costs. A new clean-sheet engine costs $6–12 billion to develop and reach certification, financed against an aftermarket that pays back over decades. Material costs spiked in 2024–25 as titanium and nickel-alloy forging capacity ran out — Safran, GE Aerospace, and Pratt & Whitney each took equity stakes in upstream forging houses (Safran in Aubert & Duval) to lock supply. Capital intensity sits around 3.5–4% of revenue in capex plus roughly 4–5% in self-funded R&D: not light, but most of it earns back through high-margin spares revenue 5–20 years later. The bargaining-power story is simple: the airframer picks the engine on each program, but once chosen, the airline is captive to the certified parts catalog. That's why the installed base, not the order book, is the real asset.

Demand, Supply, and the Cycle

The industry has three demand engines running at different frequencies:

Takeaway: the industry's downturns are almost always traffic-led, aftermarket-first — except 2024–25, where the binding constraint shifted to supply. For a propulsion-heavy supplier like Safran, the leading indicator is shop visits per engine, not airframer order intake.

Competitive Structure

Aerospace and Defense is consolidated at the top, fragmented in the long tail. Three structural rules govern competition:

1. Engines are a global oligopoly of four. CFM (the GE Aerospace / Safran 50/50 JV) and Pratt & Whitney (RTX) split the narrowbody market; Rolls-Royce dominates widebody (Trent family); CFM and Pratt are slugging it out on A320neo (CFM has held roughly 60%+ of A320neo / 60%+ of A321neo cumulative orders). On the Boeing 737 MAX, CFM is sole-source — every MAX flies on a LEAP-1B. No new Western entrant has emerged in 50 years; China's AECC is investing USD 5 billion in the CJ-1000A but is at least a decade from credible scale.
2. Equipment primes overlap by aircraft system, not by company-wide. Safran competes with Collins (RTX) and Liebherr on landing gear; with Collins, Honeywell, and Meggitt on nacelles, brakes, and electrical; with Collins and Honeywell on APUs and avionics. There is no single competitor across all of Safran's portfolio.
3. Defense is regulated and national. Each major NATO country protects sovereign suppliers: France for Safran/Thales/Dassault, Germany for MTU/Hensoldt, UK for Rolls-Royce/BAE, US for the primes. Defense competition is mostly cross-border on exports (Rafale vs F-35 vs Eurofighter), not on procurement at home.

Notice the spread: pure equipment-tilted GE Aerospace and Rolls-Royce post 18–21% operating margins because they sit purely in the high-margin engine/MRO arena, while diversified Thales runs in single digits because defense electronics is structurally lower-margin than commercial propulsion. Safran's 13% blended margin reflects half propulsion (rich) plus equipment and interiors (thinner).

Barriers to entry are essentially absolute: certified engineering know-how, type certificates, 5–10 year development cycles, and aftermarket capture make a new entrant a multi-decade, multi-billion-dollar proposition. This is why the FY2025 URD opens by ranking Safran as the "3rd global aerospace group, excluding airframers" — the entire global ranking is short enough to fit on one hand.

Regulation, Technology, and Rules of the Game

External rules in this industry are not background noise — they directly shape who can sell what, at what price, and for how long.

The single most important rule for an investor to internalize: a type certificate is a property right that the regulator enforces. Every certified part on every certified engine on every certified aircraft is a recurring annuity, defended by safety law. This is why the industry trades at premium multiples versus general industrials despite mid-teen operating margins.

The Metrics Professionals Watch

Services-share calculation: 65% × 50% Propulsion + 39% × 39% Equipment & Defense + 37% × 11% Interiors ≈ 51% group-wide aftermarket. This is the single number that separates Safran's quality from a pure airframer or commodity equipment maker.

Where Safran Fits

Safran is a diversified tier-1 propulsion + equipment prime, ranked the 3rd largest global aerospace group excluding airframers by its own reporting (after GE Aerospace and RTX once you net out airframers like Boeing and Airbus). It is not a pure engine play (MTU, Rolls-Royce) and not a pure equipment play (Honeywell Aerospace, Collins-as-segment). The closest functional analog is RTX before it bought Raytheon — a propulsion plus equipment supplier with a deep defense electronics arm.

Propulsion is the engine of value — 50% of revenue, 23% recurring operating margin, two-thirds services. Equipment & Defense is the diversifier — large, profitable, increasingly tilted toward defense. Interiors is the legacy drag being managed down.

What to Watch First

A focused checklist of signals that will tell you in real time whether the industry backdrop is improving or deteriorating for Safran specifically. Each is observable in primary disclosures.

---

Know the Business

Figures converted from euros at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Safran is a propulsion-led aerospace prime with two thirds of its franchise locked inside a single joint venture (CFM, 50/50 with GE Aerospace) that has sole-source narrowbody engines on the Boeing 737 MAX and roughly 60% share on the Airbus A320neo — a position that prints aftermarket money for 25 years per engine delivered. The market understands this is a high-quality compounder but probably under-prices the durability of the LEAP installed-base annuity while over-relying on consolidated margins that blend a 23%-margin Propulsion business with thinner Equipment and a still-loss-making Interiors arm. Read this tab as: where the profit actually comes from, why peers look better or worse than they are, and what would change the underwriting.

1. How This Business Actually Works

Safran sells engines and equipment at thin margins to capture a 25-year aftermarket annuity defended by FAA/EASA type certificates. The OE sale is the entry fee; the aftermarket is the business.

The economic engine has four legs that need to be understood together, because the operating margin of any single year is the weighted average of four very different businesses running on different cycles:

The mental model that matters: a LEAP engine delivered today is paid for by the airline at a price that earns Safran roughly nothing on the box itself, but obligates the airline to buy Safran spare parts and bring the engine back to a Safran-approved shop every 5–7 years for the next quarter-century. Each shop visit is several million dollars at gross margins that are multiples of OE margins. The type certificate, issued by EASA and the FAA, is what makes this a property right rather than a hope — the airline cannot legally fit a non-certified part. That is why FY25 Propulsion shows a 23% recurring operating margin while delivering record OE units (which alone would be loss-making), and why the next 5 years of LEAP deliveries are really 25 years of forward earnings being created.

Propulsion is half the revenue but more than two-thirds of the operating income. Everything else is decoration around that core.

2. The Playing Field

Safran sits between three pure engine plays (GE Aerospace, Rolls-Royce, MTU) and three diversified equipment groups (RTX, Honeywell, Thales) — none of them are a clean comparable, and that's the point. The peer set tells you what Safran's "good" looks like piece by piece, not as a blended whole.

Three observations make this peer set decision-useful:

Safran is in the middle of the cluster on blended margin, but the blend is what hides quality. GE Aerospace at 18.7% and Rolls-Royce at 21.1% are pure engine; their margins are what Safran's Propulsion segment alone earns (23.0%). The diversified equipment peers (RTX at 10.5%, Thales at 9.4%) drag down their consolidated numbers the same way Safran's Equipment & Defense and Interiors drag down its 16.6%. The right comparison is segment-to-segment, not company-to-company.

MTU is the cleanest pure-engine economic substitute. Like Safran Propulsion, it earns most of its income from CFM and GTF aftermarket. MTU's 13.9% margin and weak FCF margin (4.8%) reflect that it doesn't own the platform — it's a risk-sharing partner without the CFM joint venture economics that Safran owns alongside GE. MTU is what Safran Propulsion would look like without the JV.

RTX is the warning. Same business mix as Safran (propulsion + equipment + defense), 10.5% margin. The difference: Pratt's GTF is losing the A320neo battle to CFM LEAP, and Collins is more commoditized than Safran's #1-share landing-gear and carbon-brake positions. RTX shows what happens when a "diversified prime" doesn't actually win in any single lane.

3. Is This Business Cyclical?

Yes — but not in the way the cover of an industrial cycle textbook would suggest. Safran's revenue moves with two distinct cycles plus one binding constraint, and the cash flow lags the deliveries by years.

The shape of that chart is the cycle: revenue dropped from $28.2B to $17.3B in 18 months (-39%) and recurring operating income fell from $4.3B to $1.0B (-77%) — the operating leverage in this business is brutal in a downturn. Aftermarket revenue, theoretically the annuity, fell first because grounded fleets don't burn through spare parts. OE took longer to drop because deliveries were governed by airframer build-rate decisions which lagged the demand collapse by two quarters.

The non-obvious point: 2024–25 is the first cycle in Safran's history where supply, not demand, is the binding constraint. That changes the underwriting in three ways. First, pricing power is materially better than in a normal recovery — airlines are not negotiating hard on a part they can't get elsewhere. Second, working capital is structurally higher because the company is carrying inventory and receivables against constrained deliveries (FY25 receivables grew +35.5% vs revenue +12.5%). Third, the LEAP installed base is growing slower than CFM and Safran planned, which delays — but does not destroy — the aftermarket annuity. Each year of supply constraint pushes the aftermarket payoff curve to the right, not down.

4. The Metrics That Actually Matter

Stop watching consolidated operating margin. Five metrics drive value at this company, and a 200-bp move in the consolidated margin tells you less than a 5% move in any one of them.

Why these and not the usual ratios: a P/E ratio at Safran tells you almost nothing because IFRS net income in FY25 ($8.4B) is distorted by a ~$4.7B non-cash mark-to-market gain on the FX hedge book; the adjusted net profit is $3.7B. Return on equity prints at 55.6% in FY25, which is more an artifact of a thin equity base after years of buybacks than a measure of business quality. The metrics above all link directly to either the size of the future aftermarket annuity or to how much of today's profit becomes cash — those are the things that actually drive a long-duration aerospace stock.

5. What Is This Business Worth?

Value here is mostly determined by the long-duration aftermarket annuity on the CFM and Equipment installed bases, not by the year-1 operating margin. Safran is best valued segment-by-segment because the consolidated number blends a near-utility (Propulsion) with three structurally different businesses, and a single EV/EBITDA on the group will systematically misprice the quality of Propulsion.

The right way to underwrite this stock is to assign separate multiples to each segment because the cash quality is materially different. Approximate group-level math: Propulsion's $4.2B recurring operating income deserves a near-utility multiple anchored to the size and life of the CFM installed base; Equipment & Defense's $1.8B should trade in line with diversified defense-equipment peers (10–14× EBIT); Interiors is worth book value plus optionality on disposal. The reason this matters: at a single group EV/EBIT multiple of ~17×, you are paying the same multiple for Propulsion's locked-in aftermarket as for Interiors' thin-margin cabin business, which is wrong in both directions.

What would make the stock genuinely cheap: a multi-quarter air-traffic shock that knocks LEAP shop visits below baseline (the COVID pattern) while supply constraints unwind and OE leverage flips negative. What would make it expensive without changing the business: a peace-dividend reversal in NATO defense spending and a single-quarter miss on the French surtax pass-through to FCF. The asset to track is shop visits per engine; the asset to ignore is the headline P/E.

6. What I'd Tell a Young Analyst

Three things, in order.

One: the order book is the noise, the installed base is the signal. Every analyst headline you'll see this year will lead with LEAP deliveries and book-to-bill. Those matter, but they're a leading indicator of revenue 18 months from now. The thing that pays the dividend in 2035 is the CFM installed base flying through its second and third shop visit — and that installed base is already on the wing. Track shop visits per engine per year, RPFH attach rates on LEAP, and civil aftermarket USD growth. Those three numbers explain more of the equity value than the order book.

Two: distrust the consolidated margin. Group recurring operating margin moved from 15.1% to 16.6% in FY25, and every brokerage note will frame this as a margin "story." It isn't. Propulsion went from ~21% to 23.0%, Equipment & Defense was roughly flat, and Interiors went from near-zero to thin positive. The mix is the story. Watch each segment margin individually; do not let the blended number anchor your view of business quality.

Three: the long-tail bet that actually matters is RISE, not the next quarter. Safran's CFM partnership with GE is what generates the franchise; the renewal through 2050 announced in 2025 was the most important non-financial event of the year. The open question is whether the RISE program (open-rotor architecture, EIS ~2035) wins the post-LEAP narrowbody on whichever Airbus or Boeing successor goes ahead. A loss to Pratt or a new entrant puts a 20-year expiration date on the installed-base annuity; a win extends the franchise another 30 years on the same model. What would change the thesis is not next quarter's order book — it's the architecture choice on the next single-aisle airframe.

---

Long-Term Thesis — 5-to-10-Year View

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

1. Long-Term Thesis in One Page

The long-term thesis is that Safran is a regulator-enforced annuity disguised as an industrial: between now and 2035, the CFM installed base swells from roughly 45,000 engines toward 60,000, the LEAP layer compounds from a thin-margin OE drag into the dominant shop-visit franchise on every narrowbody wing, and the partnership with GE — renewed through 2050 in 2025 — locks half the economics into Safran's books for another twenty-five years past the original CFM56 end-of-life. The 5-to-10-year case works only if (a) the CFM RISE open-rotor architecture wins the next-generation narrowbody decision around 2028–2030, (b) Propulsion margin holds in the 22–24% band as the LEAP aftermarket layer adds in, and (c) management converts the headline operating income to cash at 65–75% through a full cycle rather than a single peak year. This is a long-duration compounder if those three threads hold; it is a peak-multiple cyclical if any one of them breaks. The franchise trades at 20× EV/EBITDA against GE Aerospace at 34× on the other 50% of the same CFM cash-flow stream — the spread between Safran's structurally protected aftermarket and a blended-industrial multiple is the underwriting question over a decade.

2. The 5-to-10-Year Underwriting Map

Seven things have to be true for a buyer at $347 to compound at an institutional rate of return over the next decade. Each is observable, and each has both a validating and a refuting evidence path.

Driver #1 (CFM aftermarket compounding) does the most work in the underwriting because it is already showing up in the print — the +21.6% civil aftermarket USD growth in H1-25 is faster than any plausible flight-hour growth and is the financial statement footprint of the property right earning its keep. Driver #2 (RISE) is the binary that sets the multiple beyond 2035. Drivers #3 and #4 are the financial signals to monitor that any of this is converting to cash on the way through. The investor who tracks only the first three has the thesis; the investor who also tracks the next four owns it.

3. Compounding Path

The compounding model is revenue × margin × cash conversion × capital discipline. Revenue grows at 7–9% to 2030 as LEAP deliveries ramp toward 2,000 units/year and the aftermarket installed base layers in; recurring operating margin expands from 16.6% (FY25) toward 19–20% as Propulsion sustains 22–24% and Equipment walks toward mid-teens; cash conversion runs ~70% of operating income on a clean WC basis; and the share count drifts down 1.0–1.5% per year on the live $5.8B buyback. The 2028 ambition raised mid-cycle ($8.1–8.7B EBIT, ~$24.5B cumulative FCF) is the management framing; the 2030 case is the same compounding curve extended two years.

The chart tells the cycle story plainly: revenue and ROI moved in lockstep through 2018, broke catastrophically in 2020 (-34% revenue, -77% ROI), recovered to peak in 2024, and by 2025 ROI has accelerated to a multi-year inflection as the LEAP aftermarket layer adds in. ROI growth has outpaced revenue growth in 2024 and 2025 — the operating-leverage signature of an aftermarket-rich franchise on the upswing.

The ROIC path is the most demanding test in the compounding model. Today's consolidated 5.7% understates the underlying franchise quality because the IFRS denominator carries $15.6B of goodwill and intangibles from the 2005 merger and the 2018 Zodiac deal. The path to 10%+ by 2030 requires Propulsion margin to hold the 22–24% band, Equipment to walk to 15%, Interiors to clear 5%, and no further large goodwill-creating M&A — all observable, none guaranteed.

4. Durability and Moat Tests

Five tests that determine whether Safran's franchise survives a normal 10-year stress envelope. Each pairs a competitive or financial signal with a validation and a refutation marker. The competitive tests (#1, #2) decide whether the property right holds; the financial tests (#3, #4, #5) decide whether the franchise converts to cash.

Only one of the five tests (RISE selection) is genuinely binary and existential to the wide-moat rating beyond 2035 — every other failure is a margin or multiple compression that the franchise survives. That asymmetry is the single most important fact in the durability picture: four ways to be wrong on the multiple, one way to be wrong on the franchise.

5. Management and Capital Allocation Over a Cycle

The capital allocation pattern under CEO Olivier Andriès (Jan 2021–) is the cleanest piece of evidence that this management improves rather than impairs the long-term thesis. He inherited a franchise built by predecessors — CFM JV, LEAP launch, Snecma-Sagem merger — and has spent five years compounding it rather than reinventing it. Every CMD21 target was met or beaten (revenue CAGR ~20% vs 10% promised, ROI CAGR ~30% vs 20%, cumulative FCF over $16B vs $11B), and the 2028 ambition was raised mid-cycle from $7.0–7.6B EBIT to $8.1–8.7B and from $17–20B cumulative FCF to ~$24.5B. The credibility pattern from History grades this team an 8/10 — they over-deliver on profit and cash, they walk down OE delivery guides when supply binds, and they do not narrate setbacks like the $(287)M SPI capital loss in FY25.

The capital allocation track record breaks into four clean periods of evidence:

The structural drag on alignment is the French State golden share (11.7% capital, 18.4% votes via double voting rights) — the State can block transformative change. The structural support is the activist on the register (TCI 8.1% capital, 9.6% votes) — a credible counterweight pushing for capital return discipline. Executive ownership in percentage terms is rounding error (CEO Andriès owns 0.012% of the company), so alignment runs through reputation and bonus rather than personal wealth at risk. The most important single piece of evidence for an investor underwriting the next 10 years is that CEO variable pay carries explicit working-capital and receivables weight (10% inventory + 5% unpaid receivables) — meaning the forensic tab's #1 yellow flag (FY25 receivables growing 35.5% vs revenue 12.5%) is a number this CEO is paid to fix. If that pattern reverses cleanly in H1-26, the alignment evidence strengthens; if it doesn't, the discipline assertion needs revisiting.

6. Failure Modes

Five failure modes that would force a long-term thesis revision, ranked by what would actually break the underwriting rather than the print. Failure Mode #1 (RISE loss) is the only one that flips the wide-moat rating to narrow over a 15-year horizon; the other four compress the multiple without breaking the franchise.

The red-team conclusion: the long-term thesis survives every failure mode except #1 (losing RISE) — that one structurally re-rates the franchise on a 15+ year fade clock. Failure modes #2 through #6 are multiple compressions the long-duration cash flows can absorb. An investor sizing this position should anchor risk management to the RISE/next-narrowbody timeline, not the FY26 print.

7. What To Watch Over Years, Not Just Quarters

Five multi-year observable signals that update the long-term thesis. Each is in primary disclosure or trackable in public industry sources; none requires management commentary to verify.

---

Figures converted from EUR (and peer native currencies) at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, and market shares are unitless and unchanged.

Competitive Bottom Line

Safran has a real, structurally defended advantage on commercial narrowbody propulsion — sole-source on the Boeing 737 MAX (CFM LEAP-1B) and roughly 60%+ share of A320neo orders via the 50/50 CFM joint venture with GE Aerospace, renewed through 2050. The advantage is not a brand promise; it is a type certificate on an installed base of 45,000+ CFM engines that the airline customer is legally required to bring back to a Safran-approved shop for spares and service for 25–30 years. The single competitor that matters most is RTX's Pratt & Whitney — the only firm with a certified narrowbody alternative (the GTF / PW1100G on the A320neo); everything else on the threat list either reinforces Safran's position (GE, the JV partner) or competes in narrower equipment lanes (Collins, Honeywell, Thales, Rolls-Royce, MTU). Where Safran is demonstrably weaker is pure-play margin and ROIC versus engine-only or higher-mix US peers: a 13.2% group operating margin against GE Aerospace's 18.7% and Rolls-Royce's 21.1% reflects real drag from a thinner Equipment business and a still-stuck Interiors arm — which is why the equity needs to be underwritten segment-by-segment, not on the consolidated multiple.

The Right Peer Set

Six peers cover the economically substitutable surface of Safran's three segments. Two are engine-and-equipment giants that compete head-on across most of the portfolio (GE Aerospace, RTX); one is a pure-play widebody engine peer with a turnaround story (Rolls-Royce); one is the cleanest small-cap engine-and-MRO comparable (MTU); one is a diversified avionics and APU competitor on the equipment side (Honeywell Aerospace); and one is the French defense-electronics neighbor with shared sovereign exposure (Thales). Customers (Airbus, Boeing, Embraer, Dassault), pure-aftermarket parts shops (TransDigm, HEICO, Howmet), and Collins Aerospace as a stand-alone entity are deliberately excluded — Collins is captured inside RTX, and the parts-shop economics are a different animal (smaller capital base, lower R&D).

All market-cap and EV figures as of 2026-06-05; native-currency values converted to USD at spot. Safran EV approximated from FY25 calculated TEV ($141.3B from €120.3B at €/$1.175). RTX margin is depressed by GTF powder-metal recall accruals.

The chart is the clearest one-shot summary of the competitive set: GE Aerospace sits in the top-right (pure-play engine OEM, premium multiple, expanding margin); Rolls-Royce sits mid-right (top margin, mid-multiple — the market still discounts execution risk after the 2020–22 crisis); Safran lands in the middle — paying a near-engine-OEM multiple on a blended business mix. The gap between Safran (20.3× EV/EBITDA, 13.2% margin) and GE (33.9× EV/EBITDA, 18.7% margin) is the part of the franchise the market does not give Safran credit for owning — and it sits on the wrong side of the JV economics (Safran's half).

Where The Company Wins

Four advantages stand up to direct evidence — they each tie back to a specific document or competitor disclosure rather than to a management slogan.

The non-obvious point: GE Aerospace, the partner that earns the highest operating margin in the peer set (18.7%), gets there partly because it sits on the other half of the same CFM economics that Safran owns. GE's premium multiple (33.9× EV/EBITDA) is the market's way of paying for narrowbody-engine certainty. Safran's 20.3× multiple is the market paying for half of that certainty plus a blend of less-premium businesses. The mistake the consensus makes is treating Safran's diversification as a discount factor; the JV that Safran half-owns is the same asset that lifts GE.

Scale 0–5 (0 = no presence; 5 = global #1 / sole-source). Read across rows to see who beats Safran where. Safran ties or leads in 7 of 11 dimensions; trails meaningfully only in widebody, avionics, and defense electronics — the lanes where Rolls-Royce, RTX, Honeywell, and Thales win respectively.

Where Competitors Are Better

Four specific weaknesses where peers credibly outscore Safran. None of them, on current evidence, is large enough to break the moat — but each is a measurable margin or growth gap that a thoughtful investor should watch.

Threat Map

Eight specific threats, scored by severity over the next 24 months. The map separates share-loss risk (who can take orders from Safran in 24 months — almost nobody on narrowbody, very few on landing systems) from economic-compression risk (who or what compresses Safran's margins and FCF without changing orders — supply chain, tariffs, French tax). The 24-month watch is dominated by the latter.

Severity scale: 1 = Low, 2 = Medium, 3 = High. The 24-month picture is dominated by margin-compression threats (forging supply, tariffs, French tax) rather than share-loss. The 36-month-plus picture is dominated by the RISE platform decision — the single biggest binary the market doesn't yet price.

Moat Watchpoints

Five measurable signals that will tell an investor whether Safran's competitive position is strengthening, holding, or weakening. None of these are management commentary; all are observable in primary disclosures or competitor filings.

---

Current Setup & Catalysts — The Bridge from Thesis to Print

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

1. Current Setup in One Page

The stock is trading around $347 — almost flat year-to-date, ~14% below the $405 February ATH and ~13% below sell-side mean target $400 — and the market is now mostly watching whether the H1-26 working-capital print on 28 July validates or refutes the FY26 $5.1-5.4B free cash flow guide. The recent setup is Mixed-to-Constructive on operations and Cautious on tape: FY25 results raised the 2028 ambitions, Q1 2026 came in at $10.0B (+18.8%) with LEAP deliveries +60% and spare parts +29%, the Ryanair ~2,000-engine MoU and SIA-Engineering Singapore MRO JV both extended the aftermarket annuity — but a sector-wide April-26 selloff (~16% drawdown peak to trough) produced a death cross on 8 May, realized volatility sits above the 80th-percentile stressed band, and an unresolved Pentagon-AVIC governance overhang from the 20-Mar US House letter is still open. The 28 July H1 print is the single highest-impact event in the next six months; everything else is positioning around it.

2. What Changed in the Last 3-6 Months

The recent window has been busy on operating evidence and noisy on tape. The table captures the news that actually moves the underwriting debate; an item is included only when it changes a forward number, opens a governance tail, or reshapes how the market views cash quality, moat, or capital allocation. 12-month-old items appear only if they still anchor today's setup.

The narrative arc inside the last six months is clean: investors entered the year worried that FY25 was a peak print and that consensus was lazy, then management raised both the 2028 EBIT and FCF ambitions, then Q1 confirmed the LEAP and aftermarket ramp had not slowed. The market should have re-rated — instead a sector-wide April selloff broke the tape, the death cross sealed the technical regime change, and a 20-March governance overhang on the AVIC JVs gave bears a non-numerical reason to sell. The unresolved question — and the only one that materially updates the long-term thesis on a near-term clock — is cash quality: whether the FY25 $1.16B working-capital tailwind reverses cleanly in the H1-26 print or whether the FY26 $5.1-5.4B FCF guide turns out to need the timing benefit to persist for a second year.

3. What the Market Is Watching Now

The live debate has four parts. Each pairs the watched item with what would confirm or challenge the current market view, so the PM can size the asymmetry around the 28 July print and the 23 October Q3 update.

4. Ranked Catalyst Timeline

Eight catalysts ranked by decision value to the investment debate, not chronology. The list is short because the calendar genuinely is — outside of H1 results and the Q3 trading update, most forward updaters are continuous signals (LEAP monthly deliveries, AMF short interest tape, GTF storage data) rather than discrete events. Items beyond six months are flagged.

5. Impact Matrix — Which Catalysts Actually Resolve the Debate

Four items that update the durable thesis variables, not just the next quarter. The H1 print sits at the top because it directly stress-tests the single argument both bull and bear hinge on (cash quality). Below it, the items are ranked by whether they update a long-term driver (RISE, AVIC) or a near-term evidence stream (Q3 update, surtax).

6. Next 90 Days

The window from 8 June to early September is dominated by a single event. Three sub-items frame what to track around it; everything else is noise.

7. What Would Change the View

Three observable signals would most change the investment debate over the next six months. First, the H1 working-capital reversal: a clean DSO retrace below 145 days with FCF run-rate consistent with the FY guide would close the bear case at row 1 of the short-interest ledger and force a re-rating of cash quality; an absent reversal lands the FY26 $5.1-5.4B guide on the first cut and compresses the multiple toward 13× peer-median EV/EBITDA. Second, the Pentagon disposition of the 20-March Moolenaar AVIC letter: any procurement restriction or DoJ reopening rewrites the Equipment & Defense compounding case and reaches into the governance tail; absence-of-update through Q3 effectively closes the issue for the underwriting window. Third, the durability story on LEAP-1B enhanced HPT blade certification combined with monthly Airbus engine-share data: durability validation plus held A320neo share keeps Failure Mode #2 capped and protects the 25-year aftermarket annuity for every engine delivered in the GTF window. These three tie directly back to Long-Term Thesis Drivers #1, #3, #4 (cash conversion, Propulsion margin, aftermarket compounding), Bear primary trigger (H1 receivables print), and the moat tab's competitive durability tests. The forensic, governance, and moat questions all resolve on observable evidence inside the next six months — the wide-moat thesis does not wait for RISE to be the only meaningful update.

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the CFM franchise is real and the 2050 renewal is locked, but FY25 cash flow carries roughly $1.18B of working-capital timing that the bear correctly flags as the one undisputed forensic question in this report. Bull's structural case (45,000-engine type-certificate annuity, 23.0% Propulsion margin, 14-turn EV/EBITDA discount to GE) is the stronger long-duration argument; Bear's near-term cash-quality flag is the stronger near-term argument. Both sides converge on the same evidence event — the H1-2026 receivables and DSO disclosure expected late July 2026 — which makes "wait for the print" an institutionally honest answer rather than a hedge. The tension that decides it is whether the $1.18B FY25 working-capital tailwind reverses cleanly as timing on French state customers (Bull) or unwinds as the front half of a normalized FCF reset (Bear). Until that prints, the long is justifiable on the franchise but not yet on the cash conversion the 20.3× multiple is buying.

Bull Case

The three points retained from Bull, ranked by structural weight. The fourth — the Pratt GTF storage tailwind — was dropped as a cyclical share-shift argument that Bear's symmetric "GTF recall ends 2026-27" point neutralizes.

Bull's target is $460 per share on 18× 2026 adjusted EBITDA (~$8.81B implied) against management's reaffirmed $7.16-7.28B recurring operating income, closing roughly half the 14-turn EV/EBITDA gap to GE. Timeline 12-18 months, primary evidence window the H1-2026 print in late July 2026 followed by FY2026 results in February 2027. Disconfirming signal: FY26 FCF below $4.94B with the receivables gap unwound AND Propulsion margin slipping below 21% — that combination breaks the compounding thesis and forces the long off.

Bear Case

The three points retained from Bear, ranked by sharpness. The fourth — the GTF recall ending 2026-27 and CFM share reverting to Pratt — was dropped as the symmetric pair to Bull's transient GTF tailwind; both sides accept the share dynamic but neither has the better forward visibility on it.

Bear's downside target is $274 on 13× EV/adjusted EBITDA — the peer-median ex-GE (MTU 12.4×, Thales 15.4×, Honeywell 17.1×, RR 18.0×) — against a 2026 EBITDA that consensus revises down ~5% when the WC tailwind unwinds. Net cash $2.0B credit, 417.9M shares. Timeline 12-18 months. Primary trigger: H1-2026 receivables and contract-asset disclosure (late July 2026); if DSO does not retrace below 145 days, the FY26 FCF guide comes off-table. Cover signal: clean H1-2026 receivables reversal (DSO under 145, supplier-finance disclosed under $590M) AND formal Pentagon clearance of AVIC review without procurement restriction AND Airbus/Boeing architecture commitment to CFM RISE.

The Real Debate

Three tensions where Bull and Bear interpret the same fact differently. Each row anchors on a specific figure or filing item rather than a directional opinion.

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the durable variables — the 2050 CFM renewal is a regulator-enforced annuity, the Propulsion 23.0% recurring margin and +21.6% civil aftermarket print are converting that annuity to cash, and the 14-turn gap to GE is real even after discounting GE as a clean-reporting outlier. The single most important tension is whether the $1.18B of FY25 working-capital tailwind reverses as timing on French state customers or unwinds as a normalization of cash conversion, because that is the one piece of evidence on which both sides agree the same near-term print decides the question. Bear could still be right if H1-26 receivables fail to retrace below ~145 DSO and the FY26 $5.17-5.40B FCF guide comes off-table — in that world the 20.3× multiple is exposed to peer-median gravity at ~13× and the structural cost drags (surtax, FX, AVIC) compound the de-rate. The condition that confirms the long is a clean H1-2026 receivables reversal with Propulsion margin holding at or above 23%; the condition that flips it to "Avoid" is the bear's specified trigger landing — DSO failing to retrace with the supplier-finance footnote disclosing a material balance — at which point the cash-quality argument the 20× multiple is buying breaks. The durable thesis breaker is the cash-conversion ratio of the aftermarket annuity over a full cycle, not any single print; the near-term evidence marker is the late-July 2026 H1 disclosure. Do not take size on the long ahead of the print.

---

Moat — What Protects This Business

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

1. Moat in One Page

Verdict: wide moat — but only inside the propulsion and sovereign-defense franchise; narrow on equipment; absent in interiors. The single most useful sentence in this whole report: Safran does not earn its money from selling jet engines, it earns its money from owning a property right — the EASA/FAA type certificate on roughly 45,000 CFM engines flying on Boeing 737 family and Airbus A320 family aircraft — that legally compels airline customers to bring those engines back to Safran-approved shops, with Safran-approved parts, for 25–30 years per engine delivered. That is not a brand promise or a service-level reputation; it is a regulator-enforced annuity with no certified substitute and a partner (GE Aerospace) that is contractually locked into 50/50 economics through 2050.

The strongest evidence is in three places at once: the services mix (51% of group revenue, 65% inside Propulsion — i.e., more than half the revenue comes from non-discretionary parts and shop visits on an installed base), the Propulsion segment recurring operating margin of 23.0% in FY2025 (240bps higher than FY2024 as the LEAP aftermarket layer adds in), and the civil aftermarket revenue print of +21.6% in USD in H1-25 which is materially above any plausible flight-hour growth — i.e., pricing and mix are working. The biggest weakness is the binary risk on the next-generation narrowbody architecture decision (the CFM RISE open-rotor program targeting ~2035 entry-into-service): lose the next platform and the moat has a 20-year fade clock; win it and the franchise re-extends another 30 years.

2. Sources of Advantage

The advantages are specific, not adjectival. A "strong brand" or "good execution" does not qualify; each row below ties to a regulatory, contractual, or installed-base mechanism with a quantified company-specific evidence point.

The top two rows do most of the work. Rows 3-4 are real but narrower; row 5 is the industry property that Safran shares with two other firms; row 6 is the most promising new layer the company is building but the evidence is too young to underwrite.

3. Evidence the Moat Works

The test is whether the alleged advantage shows up in actual business outcomes — margins, retention, pricing, share, or cash conversion. Six pieces of evidence make the case; one piece pulls in the other direction. Confidence is graded honestly.

The chart is the most efficient summary of the moat thesis. The within-Safran spread between Propulsion and Interiors — three segments owned by one management team, sharing back-office, balance sheet, and capital allocation — isolates the moat variable. Propulsion's 23% recurring operating margin and Interiors' 3.2% have approximately the same SG&A, the same management quality, and the same currency exposure. The 2000bp gap is the moat.

4. Where the Moat Is Weak or Unproven

Four honest weaknesses. None is large enough on current evidence to flip the rating from wide to narrow, but each is a measurable risk that an investor must underwrite separately, and a thoughtful position size accounts for the unproven portions.

5. Moat vs Competitors

The comparison is built on the seven names introduced in the Competition tab. Read row-by-row, not column-by-column, because each competitor wins on different axes — there is no single "best moat" peer; there is a peer who is stronger on each specific lane.

The map confirms the cluster: GE Aerospace is top-right (highest moat score, highest pure-engine margin, market-cap leader), Rolls-Royce sits next door on margin but with a smaller installed base and narrower platform coverage. Safran sits mid-pack on consolidated margin because of segment mix — but on a moat-strength axis it is genuinely peer with GE and ahead of P&W/RTX, MTU, and Thales.

6. Durability Under Stress

A moat is only as good as the next downturn. Six stress tests; for each, the question is whether Safran's installed-base annuity and type-certificate protection survive intact or whether the alleged advantage washes out under pressure. The relevant historical reference points are COVID (2020-21), the 2022-25 supply-chain crunch, and the 2024 LEAP delivery walk-down.

Reading this chart: five of the six stress cases produce severity ≤3 — the moat survives. The one severity-5 case (losing the next narrowbody platform) is the only stress that genuinely flips the rating from wide to narrow over a 15-year horizon. That is why the watchlist below leads with the RISE architecture signal.

7. Where Safran SA Fits

Safran is not one moat; it is three businesses with different moat profiles. Treating the consolidated number as the moat read is the most common analytical mistake on this name. The right framework is segment-specific, because a buyer of the equity is buying a weighted average of three distinct franchise qualities.

The consolidated wide-moat rating is justified because Propulsion plus sovereign-defense generate ~70% of recurring operating income and >50% of revenue, and both are structurally protected. The narrow-moat Equipment business and no-moat Interiors business are real margin drags but do not erode the protected core — they just mean the headline ROIC will be lower than the moat would otherwise produce, and the right valuation framework is sum-of-the-parts (see Business tab).

8. What to Watch

Six measurable signals that will tell an investor whether the moat is strengthening, holding, or weakening. Each is observable in primary disclosures; none requires management commentary to verify.

---

Financial Shenanigans

Figures converted from euros at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

1. The Forensic Verdict

Safran prints a Forensic Risk Score of 32 / 100 — Watch. The clean tests dominate: an unqualified opinion from the dual French statutory auditors, no restatements, no AMF or SEC enforcement, separated Chair/CEO, an activist (TCI) and the French State as independent checks on the board, and CEO variable pay tied to working capital so that inflating receivables hurts the bonus. The two real concerns are both balance-sheet flow signals: FY2025 trade receivables grew 35.5% while revenue grew 12.5% (a +23pp gap), and days-payable-outstanding stretched by +30 days to 256, supplying roughly $1.2B of non-recurring tailwind to cash conversion. The one data point that would move the grade meaningfully is the FY2026 H1 update on receivables and contract-asset balances — if the gap closes as state-customer payments arrive, this is timing; if it widens, the bull-case 75% cash conversion ambition is exposed.

Shenanigans scorecard — all 13 categories

2. Breeding Ground

Safran's breeding-ground risk is below average for a French large-cap industrial. The governance structure has multiple credible counterweights to the executive team: a separated chair (Ross McInnes since April 2015), an activist holder (TCI at 8.1% of capital, 9.6% of votes), and a French-State seat (Bpifrance/APE) sitting on the Audit & Risk Committee. The board is 58% independent, attendance averaged 98% in 2025, and the dual French statutory-auditor regime is in place. Crucially, CEO Olivier Andriès' 2025 variable pay reads like a forensic countermeasure: 60% weight on recurring operating income, 25% on free cash flow, 10% on inventories, and 5% on unpaid receivables. Inflating receivables to flatter revenue would mechanically dock the CEO's bonus.

The one yellow that matters is expectation pressure. Safran has met or exceeded every Capital Markets Day cycle since 2015, the FY2025 result beat the initial outlook on every metric, and management raised the 2028 free cash flow ambition mid-cycle from $17.6-20.0B to ~$24.7B. That track record builds management credibility, but it also raises the bar for the kind of timing-driven flatteries that show up most clearly on the balance sheet — which is where most of the yellow flags below live.

3. Earnings Quality

The IFRS income statement is dominated by below-operating mark-to-market on the USD-hedging derivative book. The chart below shows the gap clearly: IFRS net income swings from -$2,623M (FY22) to -$693M (FY24) to +$8,433M (FY25) while operating income trends smoothly upward. Recurring operating income — Safran's adjusted metric — is the cleaner read on underlying earnings, and it has compounded at roughly 30% from FY21 to FY25.

Interpretation. The net income line is, for forensic purposes, noise. The operating-income line — even before adjusted reconciliations — is what investors should anchor to. The $4.7B positive gap between IFRS pretax ($12,066M) and operating income ($4,826M) in FY2025 is almost entirely non-cash gains on FX-derivative MTM, mirrored by a $5.1B negative gap in FY2024 that absorbed the inverse MTM hit. The hedging program itself is real and substantial (~$48B notional, hedge rate 1.12), but its IFRS accounting treatment is what creates the headline volatility, not the operating business.

Revenue quality — the receivables divergence

This is the single most material forensic signal in the file. Receivables grew $6,051M in FY2025 while revenue grew $7,853M — receivables expanded by more than three-quarters of the year's revenue increase. DSO climbed from 137 to 151 days (+14 days). Management attribution in the FY2026 outlook is explicit: "subject to payment schedule of certain advance payments and the rhythm of payments by State customers" — referring primarily to Rafale and defense receivables that swing on French and export government cash. The benign read is timing on Rafale orders that booked late in 2025; the malign read is that revenue was pulled into FY25 to hit the 14.7% growth headline. The H1 2026 receivables print will tell us which it is.

Non-cash income, impairments, and the "one-off" line

The FY2025 $497M impairment charge (likely Aircraft Interiors related — the segment booked a $199M operating loss) is the largest single one-off in years and is excluded from the adjusted ROCI margin walk that drove the 150bps margin expansion narrative. That is defensible accounting treatment, but the pattern of impairments and "infrequent material non-operational items" reappearing year after year deserves the standard skeptical eye. Including the FY2025 impairment, the adjusted operating margin would have been 15.1% — flat year-over-year, not up 150bps. Both numbers are disclosed; the headline is the optimistic one.

4. Cash Flow Quality

Operating cash flow looks strong ($6,722M FY25, +21% YoY), but a meaningful slice is non-recurring working-capital benefit. The chart below decomposes CFO into the cash earnings engine versus working-capital contribution.

The headline cash conversion has held up across the cycle. FCF after acquisitions, however, fell $32M in FY2025 to $3,443M because of the $1,825M outflow for Collins flight-controls/actuation and other smaller deals. Acquisitive growth absorbs roughly 30-50% of free cash flow in active deal years (FY18 absorbed it entirely with Zodiac), so the 3-year cumulative FCF-after-M&A / NI ratio of 0.94 is the more honest cash-quality picture than the 1.17 ratio without M&A.

Working capital — where the FY2025 cash beat really came from

DSO of 151 days and DPO of 256 days are large in absolute terms but consistent with aerospace-OEM payment cycles. The forensic flag is the direction in FY2025: DSO up 14 days, DPO up 30 days, DIO flat. The DPO stretch alone is worth roughly $1.2B of cash flow that would have to reverse if Safran returns to FY2024 supplier-payment timing. Combined with the receivables surge, the FY25 working-capital print is a cocktail of state-customer timing (receivables drag) offset by extended supplier credit (payables tailwind). The headline +$1,257M WC contribution disclosed by management is a net number — it understates how much of the cash came from supplier-finance dynamics.

5. Metric Hygiene

Safran's reporting framework is transparent and reconciled, but designed to put recurring operating income front and centre. Four metrics matter.

The IFRS↔Adjusted bridge tells the real story:

• FY2024: adjusted profit $3,187M, IFRS loss $(693)M. The $3.9B gap is FX-derivative MTM losses excluded from adjusted.
• FY2025: adjusted profit $3,729M, IFRS profit $8,433M. The -$4.7B gap is FX-derivative MTM gains excluded from adjusted.

Adjusted profit growth in FY2025 was only +3.5% ($3,187M → $3,729M, in EUR terms +3.5%), versus the +26% recurring ROCI growth headline. Investors anchoring to the ROCI headline can over-estimate the underlying earnings dynamic. Both numbers are disclosed; the editorial choice of which to lead with is management's, and it leads with the larger growth number.

6. What to Underwrite Next

Five concrete things to track. Order matters: the first is decision-relevant inside two quarters; the rest are next-annual-report material.

1. H1-2026 receivables and contract assets. If FY25's $6.1B receivables build was Rafale-/state-timing, H1-26 should see a partial reversal ($1-2B unwind) and the FY26 H1 DSO should fall back below 145 days. If receivables grow another 20%+ on similar revenue growth, the FY25 14.7% revenue print includes pulled-forward bookings and the bull-case 75% cash conversion is overstated.

2. The factoring / supplier-finance note in the FY2025 URD financial statements. This is the single most useful disclosure to read at the note level. The $1.26B WC tailwind alongside +30-day DPO stretch implies either reverse-factoring or extended supplier terms that won't repeat. The note quantifies the program; the summary does not.

3. FY2026 H1 hedge book mark. The $4.7B IFRS gain in FY25 reflects a softer USD. If the EUR/USD spot reverses toward 1.05-1.10, expect a comparable swing in the other direction — pre-empt the headline shock with the adjusted profit number ($3.73B FY25).

4. Cumulative impairment / "non-recurring" item run-rate. Track the rolling 3-year sum of items excluded from adjusted ROCI. If it stays above 1.5% of revenue (FY25 print: 1.5%), the adjusted margin walk is materially flattered relative to reality.

5. Adjusted vs IFRS EPS divergence. Adjusted EPS $8.93 (FY25) vs IFRS $20.17. Use the $8.93 number for any valuation work. The $20.17 figure should never anchor a multiple.

What would downgrade the forensic grade. A second consecutive year of receivables-growth > 2x revenue growth without explicit state-customer timing being closed out; an undisclosed reverse-factoring program of more than $1.2B; a change in the definition of "recurring" or "adjusted" without prior notice; or a switch in dual statutory auditor without a clear succession explanation.

What would upgrade it. A clean reversal of FY25 receivables in H1-26, a quantified supplier-finance note that confirms the program is modest (under $600M), and continued WC contribution that comes from pricing/aftermarket rather than payable stretch.

Bottom line

This is not a thesis-breaking accounting story. The forensic risk is best characterized as a position-sizing limiter, not a haircut — investors should size Safran on adjusted earnings ($3.73B FY25) and on steady-state free cash flow excluding the $1.26B WC tailwind (~$3.3-3.5B), not on the IFRS $8.4B net income or the $4.6B headline FCF. Doing so removes most of the optical strength from the FY2025 result without changing the underlying conclusion: this is a well-governed aerospace OEM with structural aftermarket tailwinds, audited cleanly, with a credible management team. The forensic flags here would be footnotes in a less expensive stock; at current valuation, they are reasons to wait for the H1-2026 print before pressing position size.

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The People Running Safran

Governance grade: B. Roles are properly separated, the board is genuinely independent on paper and in attendance, capital is being returned aggressively through buybacks and a rising dividend, and an activist (TCI) sits on the register as a discipline mechanism. The drag is structural rather than scandalous: the French State concentrates 18.4% of votes from 11.7% of the capital via double voting rights, executives own trivially little of the company in percentage terms, and a 2022 DOJ China-bribery settlement plus a fresh 2026 US Congressional inquiry into Safran's China joint ventures keep geopolitical/governance tail risk on the table.

The People Running This Company

Safran runs the French two-board model: a non-executive Chairman who handles institutional relationships and a CEO who runs the business. Both are veterans of the group rather than parachutists, which matters in a programs business where engine certifications take a decade.

Why this matters. Andriès was running Safran Aircraft Engines — the LEAP/CFM crown jewel — for five years before becoming group CEO. He understands the program economics that drive 80% of group cash flow. McInnes was the CFO who steered Safran through the Snecma–Sagem integration and the Zodiac acquisition; keeping him as Chairman gives the board a financial counterweight to an operations-rooted CEO. The split is not cosmetic — McInnes specifically handles French State and major-customer relationships, leaving Andriès to run programs.

What's missing. Defense is now the loudest growth narrative on the calls, but the C-suite is heavy on civil-aero and engineering pedigree. Saudo at Safran Electronics & Defense is the one to watch for succession if Andriès leaves before his term ends.

What They Get Paid

Andriès' fixed salary is small for an industrial of this scale — about half what a US peer CFO typically earns. The bonus structure is sensible: two-thirds of the cash variable is hard-wired to Group financials (60% ROI, 25% FCF, 15% working capital), and his 2025 financial-objective hit rate was 111%, paying out 130% of fixed. The 2021 LTIP that vested in 2025 paid out at only 60% of target, evidence the performance hurdles bite. Total cash + grant of $4.23M is materially below what RTX, GE, or Howmet pay, which removes a typical activist target.

Are They Aligned?

This is the section where Safran's governance grade is decided. Ownership, capital returns, and insider behavior all point one direction; voting-rights concentration and absolute-dollar insider stakes pull the other.

Who actually owns Safran

The chart shows the single most important governance fact at Safran: the French State controls 18.4% of votes with 11.7% of the economics because of double voting rights on shares held for more than two years. The State has not abused that gap to date, but it means the State can block any structural change (sale, demerger, big buyback authorization) that needs a two-thirds shareholder vote. TCI Fund Management — Sir Chris Hohn's activist firm — has accumulated 8.1% of the capital (9.64% of votes) and now ranks as the largest non-State holder. TCI does not publish demands on Safran, but its mere presence has historically pushed European industrials toward buybacks, capital discipline, and clearer disclosure.

Skin in the game — and the limit of it

CEO Andriès personally holds 49,379 shares — $20M at current prices, around 4× his annual cash compensation, but only 0.012% of the company. Chairman McInnes holds 16,148 shares. In percentage terms the executive stake is rounding error; in dollar terms it is real but not life-changing for executives at this level. The 5.55% employee block (mostly via the FCPE Safran Investissement corporate mutual fund) is the more meaningful aligned holding — and it doubles to 8.57% of votes through the two-year holding rule. The score lands at 4/10: the structure rewards retention rather than ownership, and the alignment force on management is more reputational (activist scrutiny, State oversight, French press) than economic (personal wealth on the line).

Capital returns are clean

Two facts on capital allocation cut against any "complacent governance" narrative. First, Safran cancelled 5.29M shares (1.25% of the share count) in 2025 — these are real retirements, not SBC-offset buybacks. Second, the board went back to shareholders in May 2025 to lift the buyback ceiling to $18.1B and is asking for $24.6B at the May 2026 AGM. The dividend rose 16% to $3.94 (40% payout ratio of adjusted net income). Net of buybacks and dividends, Safran returned ~$3.8B to shareholders in 2025 — meaningful for a company with ~$27B of net cash adjusted for hedge book.

Dilution is negative — share count is falling

LTI grants are deliberately tiny relative to the float: the 2026 LTIP grants to the CEO and Executive Committee combined dilute the share count by approximately 0.005%. That is striking restraint relative to US peers where ~1% annual dilution is common.

Related-party flags — present but explainable

The 2025 URD lists two related-party agreements with the French State concerning ArianeGroup and its MaiaSpace subsidiary. Both relate to "sensitive" and "protected" assets in space-launcher and nuclear-deterrence programs and are required by the State's golden-share regime, not by a commercial conflict. The 2022 DOJ settlement ($17.2M) for bribery via the Monogram Systems subsidiary in China is closed, with no further prosecutions. The newer flag worth tracking is the March 2026 letter from a US House committee asking the Pentagon to review Safran's China joint ventures — this is geopolitical pressure on revenue, not a governance failure, but it could force the board to choose between Chinese commercial relationships and US defense contracts.

Board Quality

What the board does well. The non-employee independence ratio of 58.3% (7 of 12) just clears the AFEP-MEDEF benchmark for a controlled company. The 50% gender balance is genuinely there, not symbolic. Attendance was 98% across 8 meetings. The committee chairs are real heavyweights — Laurent Guillot (ex-Saint-Gobain group GM) at Audit & Risk and Patrick Pélata (ex-Renault COO) as Lead Independent Director and ITC Chair. The committee chair selecting an outside benchmark on incorporating CSR criteria into 2025 pay is the kind of process maturity activist holders look for. Fabrice Brégier (ex-Airbus COO) provides peer-level aerospace operating expertise; Fabienne Lecorvaisier (ex-Air Liquide CFO) and Valérie Baudson (Amundi CEO) bring deep finance.

What is missing. Defense and government-customer experience is concentrated in two French State directors (Fornaro, Lahousse) and McInnes — there is no truly independent director with primary US defense or NATO procurement background, which is awkward given how fast Safran is rotating toward defense revenue and given the March 2026 China-JV inquiry. Monique Cohen (joined 2013) ceased to be independent in May 2025 once she passed the 12-year tenure limit; she is stepping down at the 2026 AGM, which fixes the issue. The Appointments & Compensation Committee independence dropped from 80% to 60% during 2025 — a temporary blip from the membership rotation, but worth tracking.

What is cosmetic. The Innovation, Technology & Climate Committee is a hard sell as a governance check on a propulsion company that lives and dies by jet-engine burn — but the Climate Director Pélata is at least the Lead Independent Director, so the role has weight.

The Verdict

Grade: B. Safran governs itself like a serious European industrial. Chairman and CEO roles are separated by design, committee chairs are credible outsiders, an activist owns 8.1% and discourages drift, and capital is returned to holders aggressively through dividends ($1.65B for 2025) and real share retirements (5.29M cancelled in 2025).

The single change that would most likely cause a downgrade is a meaningful escalation of the US-China inquiry into either a formal Pentagon restriction or a renewed DOJ action — both would expose governance weaknesses in subsidiary oversight that the closed 2022 case was supposed to have fixed. The single change that would most likely cause an upgrade is the French State trimming its stake or voluntarily renouncing double voting (politically unlikely in the current Macron-era defense climate, but not impossible).

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Narrative Arc

Safran's story over the past five years is the rare case where the post-COVID restart was managed by a CEO who did not preside over the prior chapter, and where the medium-term ambitions set at the bottom of the cycle were systematically beaten — twice. Olivier Andriès took over on 1 January 2021 with revenue down 33% versus 2019 and Aircraft Interiors bleeding cash; by FY2025 revenue was $36.8B (+15%), recurring operating margin 16.6% (+150bps YoY), free cash flow $4.6B, and management raised its 2028 EBIT ambition from $7.0–7.6B to $8.1–8.7B. The single ugly stretch in the period — the 2024 LEAP delivery walk-down from +20–25% to ‑10% — was acknowledged and absorbed without a profit miss. Credibility has hardened rather than eroded.

Anchor dates

• Current chapter began: 2021 — Capital Markets Day in December 2021 set the 2021–2025 ambitions (10%+ revenue CAGR, 16–18% margin, >$11.8B cumulative FCF) that frame every subsequent earnings call.
• Current CEO arrived: 1 January 2021 — Olivier Andriès, formerly CEO of Safran Aircraft Engines (2015–2020), promoted from inside. Pascal Bantegnie became CFO in 2022. Ross McInnes has chaired the Board since 2015.
• The business Andriès inherited was high-quality at the core (CFM56/LEAP joint venture with GE, dominant narrowbody franchise) but with a loss-making Aircraft Interiors division acquired in 2018 (Zodiac, $9.7B) and a balance sheet bruised by COVID. The franchise is largely not of his making; the operational turn and the buy-back-heavy capital return is.

What Management Emphasized — and Then Stopped Emphasizing

Topic frequency was reverse-engineered from earnings transcripts (Q2 2024 through Q4 2025) and annual report MD&A. Intensity 0–5; higher means more airtime and more management words spent. A few themes are now load-bearing; a few have been quietly demoted.

What grew

• Civil aftermarket moved from a recovery story to the story. By FY2024, every quarter opens with the aftermarket print before LEAP deliveries are even mentioned. The reframing matters: management now tells investors to value the LEAP installed base and shop-visit pipeline, not the OE unit count.
• Defense became a 2025-vintage talking point. Rafale orders (12 to Serbia, plus France domestic), AASM/Hammer, navigation, and the new Riyadh Air engine commitments fill out a segment that used to be background.
• Shareholder returns scaled from a dividend story ($2.29 in 2024) to a $5.2B buyback plan announced at CMD'24, plus a 16% dividend hike to $3.94 in 2025. Capital return is now front-loaded into every quarterly script.
• M&A / portfolio reshaping is the loudest new theme. Preligens (AI, Sep 2024), CRT (engine MRO, Jan 2025), Collins flight controls ($725M in 5 months at close, Jul 2025), plus divestments of Roxel, EZAir, Safran Passenger Innovations.

What quietly faded

• COVID recovery framing disappeared from the script by FY2024 — the "vs 2019" comparison is gone, replaced by "vs prior year". Management stopped fighting the old war.
• Zodiac integration narrative is essentially absent now. With Aircraft Interiors at $28M positive recurring operating income in 2024 (vs $(128)M loss in 2023), management folded the topic into normal segment reporting and stopped talking about it. The 2025 $(287)M capital loss on the Safran Passenger Innovations divestment was disclosed but not editorialized — a quiet admission that part of the Zodiac bet did not work.
• Hydrogen and exotic-tech aviation (EcoPulse, BeautHyFuel) get one slide a year now versus a multi-page sub-section in FY2021. Storytelling has moved from "we are reinventing aviation" to "75% of self-financed R&D goes to decarbonization" — a metric, not a narrative.

Risk Evolution

Risk Factors heatmap, scored from URD risk-factor sections (importance: critical = 5, significant = 4, moderate = 3, low = 2). 2025 risk factors are formally "unchanged vs. 2024" by management's own labeling, so the right read is what the level of each risk was during the period, not whether the label changed year over year.

What is more important now than it was

• Supplier and subcontractor capacity moved from "moderate" to "critical" in 2022 and has stayed critical every URD since. Management calls it out as the watch item at every guidance update. The Q1 2025 strike at a French facility was the first specific operational disruption flagged on a call.
• US tariffs and the French corporate surtax entered the risk vocabulary in late 2024 and have material P&L impact ($443M cash outflow in 2025; ~$547M forecast for 2026). Management folded the tariff impact into the raised 2025 guidance — a confident gesture, but the cumulative fiscal drag is real.
• Geopolitical / sovereignty went from background to foreground after 2022. The French government holds ~11% of shares, defense represents an expanding revenue line, and the CEO has publicly warned that French budget instability threatens the defense procurement pipeline.

What is no longer load-bearing

• COVID and pandemic disruption vanished from the risk register's actionable focus by 2024.
• Zodiac-era integration risk was retired from risk discussions once Aircraft Interiors turned profitable in 2024.

How They Handled Bad News

The single largest credibility test in the period was the 2024 LEAP delivery guide walk-down. Initial February 2024 guide was +20–25%; the actual outcome was ‑10%. That is a 30+ percentage point miss on the most visible OE number in the deck. Here is how the quarterly drift looked.

What they did not do is hide it. Each quarter, the slide showing the prior-quarter guide alongside the new one was kept in the deck — investors saw the walk-down in plain sight. What they did do is keep raising the EBIT guide on the same calls, citing customer mix and aftermarket strength. That trade — "OE units are slipping but price/mix and services more than cover" — proved correct: FY2024 ROI came in at $4.28B, above the original $4.2B guide. The pattern repeated in FY2025: original guide $5.52–5.64B ROI, raised three times, actual $6.11B.

The 2024 episode set the template for how Andriès handles disappointment — acknowledge the miss on the watched OE metric, walk the offsetting commentary up to the mix and aftermarket, deliver above the original profit number. So far, that template has held.

The other quiet bad-news disclosure: a $(287)M pre-tax capital loss on the January 2026 divestment of Safran Passenger Innovations. The narrative around SPI had been muted since 2023; the loss was disclosed in the FY2025 press release without any retrospective explanation of why the business was sold below book. This is the single instance in the period of management not explaining a setback in full.

Guidance Track Record

Only the guidance items that matter to valuation are included — top-line, EBIT, FCF, and the LEAP unit guide because it is the single most-watched data point.

Guidance accuracy — FY2024 walk and FY2025 chase

The pattern: top-line guides land close to initial (because the OE walk is offset by aftermarket strength); profit and cash guides are consistently beaten by 5–35% versus the initial number. Only the LEAP unit guide blew up — once.

Credibility score

Why 8/10: Every CMD21 financial ambition was met or beaten — revenue CAGR ~20% vs 10%+ promised, ROI CAGR ~30% vs 20%+, cumulated FCF >$16.5B vs $11.8B promised. The 2025 outlook was raised three times and still beaten. The one credibility-relevant miss (FY2024 LEAP delivery walk) was disclosed transparently and didn't bleed into the profit line. The deduction (–2): the LEAP walk itself was a 30+ point swing on the most-watched OE metric, and the $(287)M SPI divestment loss was not narrated. Management is highly credible on capital return and margins, less so on supply chain timing — but they have stopped pretending they can forecast LEAP units with precision, and that itself is a credibility-positive admission.

What the Story Is Now

The current story is not the story Andriès inherited. The 2025 closer is: a high-margin, cash-generative civil aerospace propulsion franchise (the CFM56 aftermarket is now expected to be larger than CMD'24 modeled, and LEAP shop visits are ramping faster than expected), a re-energized defense business, a finally-profitable interiors division, and a balance sheet that funded $2.3B of buybacks over 2024–2025 plus $1.9B of M&A in 2025 alone while staying net cash positive ($2.0B) and S&P A‑.

What has been de-risked

• Aircraft Interiors profitability. Six years of losses turned to $28M positive ROI in 2024 and continued to grow in 2025. The Zodiac question is closed.
• 2025 CMD ambitions. All three financial targets — revenue, ROI, FCF — beaten by wide margins.
• Balance sheet. Net cash $2.0B at end-2025, even after $1.9B of M&A and the $5.8B buyback launch. The 2027 and 2028 OCEANE convertibles were both early-redeemed without dilution.
• Aftermarket model. The shift from selling OE engines below cost to monetizing them via RPFH service contracts and spare parts is no longer a thesis — it is the cash machine.

What still looks stretched

• Supply chain. Five consecutive URDs have flagged it as critical. The LEAP delivery walk in 2024 showed it can still bite hard. The "we have caught up" claim made every quarter requires the same skepticism as a tech company saying "AI is in the pipeline".
• 2028 ambitions raised to $8.1–8.7B EBIT. Even after the upgrade, hitting this requires LEAP installed base to roughly double from 2025 to 2030 (per management slides) and the third-party MRO share to triple to 30%. Both are achievable, neither is automatic.
• French fiscal drag. Surtax cash impact $443M in 2025 and ~$547M in 2026, with the abolition of CVAE postponed to 2028–2030. Political risk on top of CFM56/LEAP and tariff exposure is more than a footnote.
• Tariff pass-through. Management says it "plans to pass these costs onto customers" — that is asserted, not yet proven across a full cycle.

What the reader should believe vs discount

Believe: the capital-return commitment ($5.8B buyback over 2025–2028 is well under way, with $2.3B already cancelled), the 16–18% margin band as durable, and that aftermarket strength compounds for years before the next OE cycle starts. The team has earned the benefit of the doubt on margins and cash.

Discount: the precision of any OE/LEAP unit guide given for the current year. Management itself has stopped offering tight ranges (the 2025 figure shifted from +15–20% to "more than 20%" to actual +28% across two updates). Anchoring to the profit and cash guides — not the OE counts — is how to read this team's outlook.

The Andriès chapter is now five years old, the operating team has compounded credibility, and the strategic story has simplified rather than stretched. That is the most important thing about the current story: it is shorter, plainer, and more numerical than the story five years ago — and so far, the numbers keep landing on the right side.

---

Financials — What the Numbers Say

Figures converted from euro at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

1. Financials in One Page

Safran is a $36.6B-revenue, A- rated, net-cash aerospace prime where the cash-generative aftermarket — primarily CFM56 and a maturing LEAP services book — does the economic work. The 2025 financials confirm that thesis: organic revenue grew 14.8%, recurring operating margin stepped up 150bps to 16.6%, free cash flow rose 23% to $4.6B, and the balance sheet ended the year with $8.3B of cash against $6.3B of gross debt. Reported (GAAP) net income is volatile because Safran fair-values its multi-year USD hedge book through P&L — the swing from −$693M in 2024 to $8.4B in 2025 is almost entirely hedge mark-to-market noise, not earnings power. Valuation is full but not stretched: at $349 the stock trades at 20x EV/EBITDA and ~17.3x reported P/E, a premium to MTU (12x EV/EBITDA) and Thales (15x), in line with Rolls-Royce (18x), and a clear discount to GE Aerospace (34x). The single financial metric to watch in 2026 is free cash flow conversion — management has guided to $5.2–5.4B FCF after a $(552)M French surtax hit, and any slippage in LEAP deliveries or in customer advance payments would visibly compress it.

2. Revenue, Margins, and Earnings Power

Safran's economic profile changed materially after 2020. The company moved from a high-cycle aerospace supplier with operating margins in the 10–15% band to a high-aftermarket franchise with recurring operating margins now stepping through 16% and management's stated path to 22–24% in Propulsion alone by 2028. Revenue compounded at 8.1% from 2005 to 2025 with a clean cyclical scar from COVID; underlying organic growth across 2023–2025 has averaged 14% per year as the global engine fleet returned to flying hours and as the CFM56 aftermarket entered its peak earnings window.

The 2020 collapse — revenue down 34% — is the COVID grounding of the commercial aircraft fleet, the only macro event in two decades that genuinely broke Safran's business model. The recovery was complete only in 2024 by revenue and in 2025 by margin. The $36.6B 2025 outturn already exceeds the 2019 pre-pandemic peak by 30%.

Two reads on margins matter. First, gross margin is anchored near 47–50% and has been remarkably stable through the cycle — that is the engine aftermarket's pricing power showing through. Second, the gap between adjusted and consolidated operating margins matters because the LEAP ramp continues to absorb negative recurring P&L through the customer-installation step. On adjusted reporting Safran's 2025 recurring operating margin reached 16.6%, up 150bps versus 2024, with Propulsion at 23% (+240bps), Equipment & Defense at 12.7% (+50bps), and Aircraft Interiors finally turning positive at 3.2% from 0.9%. Margin direction is the strongest single fundamental signal in the file.

Safran reports formally on a half-year cadence; the chart confirms the acceleration into the 2H25 ramp. Management's Q1 2026 trading update reports LEAP deliveries up more than 60% year-over-year, spare-parts revenue up 29%, and services revenue up 43% — i.e., the ramp into 2026 has not slowed.

3. Cash Flow and Earnings Quality

Free cash flow is cash from operations minus capex; for Safran it is the most reliable economic-reality number on the page. Management uses a slightly tighter definition that nets proceeds from disposals from capex and includes intangible capex, which is why their reported figure ($4.6B in 2025) differs marginally from the consolidated calculation ($5.3B). We use Safran's reported figure for comparability with guidance.

This chart is the single most important diagnostic in the deck. Net income in 2022 was −$2,623M and in 2024 was −$693M, while operating cash flow in those same years was +$3,781M and +$4,917M respectively. The negative net income in those years is not an operating loss — it is the IFRS fair-value charge on Safran's three-to-four-year forward USD hedge book swinging against the company when the USD strengthened. In 2025 the USD weakened, the hedge book swung the other way, and net income inflated to $8.4B. Cash flow ignores this entirely.

FCF margin has stepped up from a 10–11% post-pandemic band to 13–15% over the last three years and management's 2024–2028 ambition targets a roughly 70% FCF-to-recurring-operating-income conversion, implying a $5.2–5.4B FCF in 2026 absorbing a $(552)M French corporate surtax. That conversion ratio is the rate at which Safran turns operating earnings into shareholder-distributable cash; 70% is in line with the best mature aerospace operators and well above defense primes that fight working-capital and inventory drag.

Major 2025 cash-flow line	$M	Comment
Net income (IFRS)	8,433	Inflated by USD-hedge mark-to-market
Operating cash flow	6,722	True earnings-into-cash bridge
Capex (PP&E + intangibles)	(1,455)	4.0% of revenue; high cycle reinvestment
Free cash flow (Safran adj.)	4,607	+23% YoY; 12.6% of revenue
Dividends paid	(1,429)	$3.94/share proposed for 2025, +16%
Buybacks	(1,596)	Part of $5.9B authorization in progress
Acquisitions	(1,825)	Collins Aerospace actuation/flight controls deal
Net debt issuance / (repayment)	(250)	Net deleveraging

4. Balance Sheet and Financial Resilience

Safran ended 2025 with $8.3B of cash against $6.3B of total debt — a net cash position of $2.0B. Net debt / EBITDA is negative; interest coverage on the consolidated income statement is in the high teens. S&P holds the long-term issuer credit rating at A− with stable outlook, the strongest balance sheet of the European aerospace primes.

The deleveraging tells the COVID-recovery story. Safran took its leverage from 0.4x to net-cash by 2022 and has stayed there as cash piled up faster than acquisitions could deploy it. That balance-sheet runway has two implications for an investor: first, the company can absorb a bolt-on deal the size of the Collins actuation/flight-control acquisition ($1.83B in 2025) without changing its rating; second, capital returns can keep stepping up — the $5.9B buyback authorization and a 16% dividend increase in 2025 are not constrained by debt service.

Resilience metric	Latest	Read
Cash and equivalents ($M)	8,270	Comfortable; covers any single bullet maturity
Total debt ($M)	6,258	Down from 2019 peak of $8,183M
Net debt / EBITDA	−0.24x	Net cash; vs RTX 2.1x, HON 2.4x
Current ratio	0.92	Below 1.0 due to advance-payment liabilities, not a liquidity warning
Working capital (receivables + inventory − payables) ($M)	13,700	Up 35% YoY on volume and Collins consolidation
Goodwill + intangibles ($M)	15,578	21% of assets; aggregate of Snecma/Sagem and acquisitions
S&P rating	A−, stable	Investment-grade with headroom

The single balance-sheet line to watch is working capital: receivables jumped from $11.4B to $17.4B and inventory from $9.9B to $12.1B in 2025. Part is the Collins acquisition; the rest is LEAP ramp-related. Working capital is the lever that can pull FCF down if customer payments slip — Safran's 2026 FCF guidance is explicitly contingent on "the payment schedule of certain advance payments and the rhythm of payments by state customers."

5. Returns, Reinvestment, and Capital Allocation

Return on invested capital (NOPAT divided by debt plus equity) is the single best measure of value creation. For Safran the picture is improving but not yet exceptional in absolute terms — 5.7% in 2025 — because the IFRS denominator includes $15.6B of goodwill and intangibles from the 2005 merger and successive bolt-ons. Stripping those out, return on tangible capital is materially higher and consistent with a moaty aerospace franchise.

ROE is wildly distorted by the hedge accounting that runs through net income (which is also why the −20% in 2022 and 56% in 2025 are not real). ROIC is the cleaner read and the trajectory is what matters: 6%–7% pre-COVID, mid-single-digits as Aircraft Interiors and the LEAP installation drag absorbed capital through the recovery, now rebuilding toward 7%+ as Propulsion margins step up.

Capital allocation has been disciplined. Safran does not buy growth at any price: the 2018 Zodiac integration produced a year-of-acquisition charge that still shows up in returns, but recent deals (Aubert & Duval 2024, Collins actuation/flight controls 2025) are tightly scoped, strategically aligned, and small relative to the cash generation. Buybacks have grown from a token $83M in 2021 to $1.60B in 2025 and management reiterated the $5.9B multi-year authorization. The dividend rose 16% in 2025 to a proposed $3.94 per share and has been raised in six consecutive years.

Net share count is down 3% over the eight years shown, with buybacks now starting to bite. At the current pace of $1.5–1.6B annual repurchases against a $146B market cap, buyback yield runs at roughly 1.1% per year — modest, but additive to a 1.1% cash dividend yield. The buyback program is not the central thesis; management is reinvesting growth capex back into the LEAP-ramp tooling and into capacity for the Defense order book.

6. Segment and Unit Economics

Three segments carry the business, all reported on Safran's adjusted basis. Propulsion is the engine that drives the economics — quite literally: in 2025 it produced 50% of revenue but 69% of recurring operating income at a 23% segment margin. Equipment & Defense is the secondary profit engine (30% of operating income at 12.7% margin), expanding fast on the Collins actuation deal and on Rafale-driven defense orders. Aircraft Interiors is the laggard — $3.9B of revenue produces just $127M of operating income at a 3.2% margin — but it is finally turning the corner after years of post-Zodiac restructuring.

The cash-flow split is even more concentrated than the operating-income split. Propulsion produced $3,282M of FCF on $18,410M of revenue (18% FCF margin); Equipment & Defense almost doubled FCF to $1,284M on the Collins deal absorption; Interiors finally generated positive FCF for the first time in five years ($11M). The 2028 ambition raises Propulsion's margin band to 22–24% as a structural floor, lifts Equipment & Defense to mid-teens, and lowers Interiors' ambition to high-single-digit margins from previous ~10% — a candid downgrade of the most challenged segment.

7. Valuation and Market Expectations

At $349, Safran trades on three valuation triangulation points: 17.3x reported P/E (heavily distorted by 2025's hedge-gain inflated net income), 20.3x EV/EBITDA, and 8.4x book. The EV/EBITDA is the cleanest measure because it sidesteps the hedge accounting and uses the same denominator (consolidated EBITDA) that the sell-side uses. A more economically meaningful P/E on Safran's adjusted recurring net income would sit closer to 24–26x — still a premium to the 10-year average but justifiable given the cash-flow step-up and the visibility of the 2028 ambition.

The 2025 EV/EBITDA of 20.3x is in the upper quintile of Safran's own 10-year range, peaking only above the 2020 COVID-distorted print when EBITDA had collapsed. That tells the reader two things: the market is paying for visibility and for the 2028 ambition, and there is little room for execution disappointment. The implied 2026 EV/EBITDA on management's $7.2–7.3B recurring operating income guidance falls to roughly 16–17x, a more comfortable multiple if numbers hit.

The current price sits roughly 13% below the sell-side mean target of $403, and inside a 12-month range of $296–$412 driven by April–May aerospace pullbacks on tariff and Middle East geopolitical noise rather than on company-specific deterioration. The bull-case is built on the 2028 propulsion margin overshoot (22–24% delivered earlier than expected) plus continued buyback execution; the bear-case is the inverse — supply-chain delivery slippage on LEAP or a working-capital-driven FCF miss in 2026.

8. Peer Financial Comparison

Six economically comparable listed peers, anchored to the FY2025 reporting period and converted to USD at period-end FX. Safran's row is the third entry. Three financial dimensions stand out: Safran has the strongest balance sheet (net cash, A− rating), middle-of-the-pack ROIC (5.7%, between RTX at 5.6% and HON at 10.9%), and a valuation multiple in line with the European pureplay engine peer (MTU) and a discount to the US engine purplay (GE Aerospace). Rolls-Royce screens cheaper than Safran on every multiple after a violent earnings recovery — but with higher execution risk in its widebody durability story.

The peer table makes the Safran investment case visible in one row. The adjusted operating margin (16.6%) is higher than every peer except Rolls-Royce (which benefits from a non-recurring service-pricing reset) and Honeywell (a more aerospace-equipment-weighted mix). Free-cash-flow conversion is best-in-class outside of Rolls-Royce. Leverage is uniquely conservative. The valuation gap to GE Aerospace — 20x EV/EBITDA vs 34x — is the biggest single observation on the page: GE has cleaner reporting (no IFRS hedge mark-to-market), a slightly higher EBITDA margin, and full US listing premium, but Safran owns 50% of CFM International with GE and shares the LEAP cash-flow stream economically. A persistent 14-turn EV/EBITDA gap between the two CFM owners is unusually wide.

9. What to Watch in the Financials

Metric	Why it matters	Latest (FY2025)	Better	Worse	Where to check
Free cash flow	Cleanest measure of economic earnings; ignores hedge accounting	$4,607M	Above $5,400M in 2026	Below $5,200M in 2026	Annual report / H1 update
Recurring operating margin	Direction of business-mix improvement (aftermarket vs OE)	16.6%	≥18.0% in 2026	≤16.0% in 2026	Annual report / segment data
Propulsion margin	The single biggest profit lever; 2028 target 22–24%	23.0%	Sustain ≥23% through 2027	Drop below 21%	Segment results
LEAP deliveries (units)	Volume driver for OE revenue and downstream aftermarket build-up	1,802 (+28%)	+15% in 2026 vs guide	Below +5%	Quarterly trading updates
Net cash / (debt)	Resilience and capital-return capacity	+$2,012M cash	Sustained net cash	Net debt > $6B (large M&A)	Balance sheet
Working capital	Drives FCF conversion; biggest 2026 risk per guidance	$13.7B	Decline as advances normalize	Growth above receivables / revenue growth	Cash-flow statement
FCF / Recurring op income	Capital efficiency of the franchise	75%	≥70% sustainably	Drops below 65%	Annual report
Buyback execution	$5.9B authorization in flight	$1.60B done in 2025	Full $5.9B completed by 2027	Pause / cancel	Capital return disclosures

The numbers confirm a franchise in the early-middle innings of a multi-year margin and cash-flow expansion. They contradict any framing of Safran as a deep-cyclical industrial — the cash-conversion profile, the net-cash balance sheet, and the segment economics belong to a high-quality compounder. The single tension between the reported financials and the market price is the IFRS net-income headline, which oscillates with the FX hedge book and creates trading-desk confusion roughly twice a year; an investor who understands that this is hedge accounting and not operating earnings can underwrite the franchise with conviction.

The first financial metric to watch is the 2026 free cash flow result. Management has guided $5.2–5.4B, absorbing a $(552)M French surtax. Anything inside that band confirms the 70% conversion ratio and the 2028 ambition; a miss below $4.9B — most likely sourced from delayed customer advance payments on LEAP or on French Rafale — would force a re-rating of the multiple and would be the first quantitative signal that the operating story is decelerating.

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

What the Internet Knows About Safran

The Bottom Line from the Web

The filings tell you Safran is firing on all cylinders — record $36.8 billion 2025 revenue, raised 2028 ambitions, dividend up, buyback live. The web adds two facts that don't sit in the URD: on 20 March 2026 the chair of the US House Select Committee on China asked the Pentagon to review Safran's joint ventures with AVIC, which — alongside the legacy 2022 DOJ FCPA declination — is a live governance/regulatory overhang on US defense contracts. And on 18 February 2026 a threat actor claimed to be selling a 1M-row Safran supply-chain dataset (parts, customers, suppliers); the company denied a cyberattack but the integrity question is now in circulation.

What Matters Most

1. US House panel asks Pentagon to review Safran's China JVs

This is the single biggest non-financial overhang because Safran is also a US DoD contractor. The 2022 FCPA declination (see #6) means Safran has prior compliance obligations the inquiry could reactivate. Material for FY2026/27 if any DoD restriction follows.

2. Collins flight controls/actuation deal closed — Safran becomes global leader, but DOJ forced a divestiture

This is the largest M&A under CEO Olivier Andriès and the second-largest competitive surface (after engines) where Safran now leads. UK CMA also signed off; EU antitrust approval came 04 April 2025. Trimmable horizontal stabiliser actuators (THSAs) for large aircraft were the specific DOJ concern.

3. FY2025 was the strongest year on record and 2028 ambitions were raised

Q1 2026 beat consensus on civil engines. The combination of record backlog, strong cash generation, and raised long-term targets sets the bull case the market is partly pricing.

4. April 2026 aerospace stock rout — Safran lost ~20% from peak

The pullback wasn't Safran-specific — it was a sector reset on Middle East tension and airline demand fears. The technicals tab flagged a "death cross" on 08 May 2026.

5. AGM 2026 — $3.94 dividend approved, buyback continues

Total return commitment intact; share capital totals 418,344,626 shares at 31 Dec 2025 with 530,198,467 theoretical voting rights (double-voting structure).

6. Cybersecurity incident — threat actor offers 1M-row Safran dataset

For a tier-1 aerospace/defense supplier this is a national-security signal even if the leak proves overstated. Pair with the AOG Technics fake-parts case (#10) — defense-supply integrity is a sticky theme.

7. SPI divested at a $(287)M pre-tax loss; Aircraft Interiors strategic review continues

This continues the unwind of the 2017 $9.0B Zodiac Aerospace acquisition (€8.5B). The Cabin and Seats franchise has incurred goodwill impairments every couple of years; the FY2025 results carried an additional $497M impairment excluded from adjusted ROCI.

8. India revenue expected to triple to over $3.4B by 2030

9. CFM's GTF competitive advantage is intact through 2026

CFM's enhanced LEAP-1A HPT blades were certified December 2024 (with 1B certification expected 2025) — designed to double time-on-wing in hot/dusty environments. The combination should preserve LEAP's share lead while GTF works through its rework cycle.

10. Ryanair MoU adds long-term annuity to LEAP/CFM56 aftermarket

This is what the Propulsion aftermarket annuity looks like in practice. Coupled with new RPFH (Rate-Per-Flight-Hour) contracts (e.g., Air Travel China, $992M, 12 years), it secures decades of installed-base revenue.

Recent News Timeline

What the Specialists Asked

Governance and People Signals

Olivier Andriès — CEO since 1 January 2021. Age 64. École Polytechnique / École des Mines de Paris. Was CEO of Safran Aircraft Engines 2015–2020 and CEO of Safran Helicopter Engines 2011–2015. Chevalier de la Légion d'honneur (2018). 2022 variable compensation $1.14M (134% of fixed pay) on 109% financial-objective achievement.

Ross McInnes — Chairman since April 2015. Age 72. Prior roles: Deputy CEO of Safran (2011–2015), Vice-Chairman of Macquarie Capital Europe, CFO of Thales, CFO of Eridania Beghin-Say. The 2017 letter from TCI's Chris Hohn was addressed to McInnes — historical context for chairman/activist relations.

Pascal Bantegnie — CFO since 2021. Age 56.

Insider holdings are ~16–17% (Yahoo Finance), with double-voting rights structure (418.3M shares vs. 530.2M theoretical voting rights at 31 Dec 2025) amplifying the French State's effective voting power.

Governance overhangs to monitor:

Pentagon / China JV inquiry — 20 Mar 2026 letter from House Select Committee on China is the active item. No formal restriction yet.

2022 DOJ FCPA declination — Safran agreed to continued cooperation; declination is conditioned. The 2026 China-JV inquiry could plausibly reopen scrutiny on the related-but-distinct China activity surface.

Cyber/data integrity — Feb 2026 alleged data leak (Safran denies); 2023 misconfiguration was previously reported by Cybernews. Defense-supply-chain integrity is the systemic concern.

Aircraft Interiors / Zodiac strategic review — $(287)M SPI loss realized; up to $1.76B more interiors under review; one-off impairments continue. Watch for a clean exit signal.

Industry Context

The aerospace cycle the web sees is straightforward: civil aviation rebound is real, narrowbody backlogs are at record levels, and defense budgets are rising. The structural twist is that Pratt & Whitney's GTF rework keeps ~33% of the GTF fleet grounded into 2026, handing CFM (Safran/GE) a multi-year competitive tailwind that the market has partly priced but not fully — Bechai's "disconnect" thesis turns on exactly this.

A second structural shift is the post-LEAP architecture decision (mid-2030s). CFM's RISE open-rotor demonstrator is the public bet; it would re-up Safran's narrowbody monopoly if Airbus and/or Boeing pick the architecture. RTX/Pratt is working on a competing next-gen ducted turbofan. This is the largest binary in the Safran story and the market does not currently price it.

Defense exposure is being repriced upward across European primes ("EU must improve defense strategy and unite against Russia, Safran says" — CEO Andriès on CNBC, Dec 2024). The Rafale export annuity (India $3.4B+ by 2030, Egypt, Croatia, Greece, Indonesia, UAE orders) is a real beneficiary; the M88 ramp at Évry-Corbeil and the new Le Creusot capacity (announced Jan 2026) are the visible industrial response.

The April 2026 stock rout was a sector reset — Bloomberg called it "Europe's Aerospace Stocks Rack Up Biggest Weekly Losses in Years" — and the Bechai bull case argues the disconnect between fundamentals (LEAP attach rates, Rafale exports, Collins integration, net cash) and the post-drawdown price is the variant perception worth owning.

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Web Watch in One Page

Safran is a regulator-enforced annuity priced at 20.3x FY25 EV/EBITDA — well above the ex-GE peer median (~13x) and well below GE Aerospace at 33.9x on the other 50% of the same CFM cash-flow stream. The report's verdict ("Lean Long, Wait For Confirmation") rests on three open questions that map cleanly to five live watch items: whether the FY25 cash flow holds up after a roughly $1.2B working-capital tailwind, whether the US-China governance overhang on the AVIC joint ventures closes quietly, and whether the moat extends into the next narrowbody architecture decision around 2027-2030. Two further items track the hardest cyclical and structural inputs the multi-year cash conversion thesis depends on: the GTF rework window and the French exceptional corporate-income surtax. The set is deliberately weighted to multi-year thesis variables over the late-July H1-2026 print, while still catching the disclosure that decides that print.

Active Monitors

Rank	Watch item	Cadence	Why it matters	What would be detected
1	Cash conversion durability of the CFM aftermarket annuity	Daily	The single near-term debate both bull and bear converge on: whether FY25's $4.6B FCF is real net of the $1.2B working-capital timing flagged in Forensics, and whether the FY26 $5.2-5.4B guide holds. A permanent reset toward 60% conversion would compress the multiple to the peer-median 13x.	Receivables / DSO movements, supplier-finance footnote disclosures, contract-asset bridges, customer-advance commentary, AMF filings, pre-announcements, profit warnings, and any "subject to" hardening in the FY26 cash guide.
2	Pentagon and House Select Committee review of Safran-AVIC joint ventures	Daily	Single biggest non-financial overhang. A US Department of Defense procurement restriction would force a choice between Chinese commercial revenue and US DoD contracts — directly impairing the Equipment & Defense segment compounding case and reaching into the governance tail.	Pentagon response to the 20 March 2026 Moolenaar letter, any DoD procurement guidance affecting Safran, any DOJ action reopening the legacy FCPA matter, House Select Committee follow-ups, or Safran disclosures restructuring or carving out the AVIC commercial joint ventures.
3	CFM RISE program and next-generation narrowbody architecture commitment	Weekly	The only failure mode rated existential to the wide moat beyond 2035. Winning the post-LEAP architecture extends the 50/50 JV economics for another 30-year aftermarket cycle; losing it begins a 20-year terminal-value fade clock regardless of the next five years of cash flow.	RISE demonstrator status, fuel-burn validation versus the more-than-20% target, Onera or wind-tunnel results, Airbus / Boeing successor-program disclosures, formal launch-propulsion announcements naming CFM, and competing demonstrator progress from Pratt & Whitney, Rolls-Royce UltraFan, or new entrants.
4	GTF rework progress, A320neo engine share, and LEAP-1B blade certification	Daily	CFM's 60%+ A320neo cumulative share is partly propped by 835 Pratt-powered aircraft stored at Oct-25. Each 5-point share shift back to GTF removes roughly 100 LEAP deliveries per year compounding for 25 years per engine of forward aftermarket.	Airbus monthly orders and deliveries, RTX disclosures of cumulative GTF financial impact, stored-aircraft counts and storage rate, EASA / FAA certification of the LEAP-1B enhanced HPT blade, and any 4-quarter window where Pratt wins more than 50% of new A320neo selections.
5	French 2027 budget and corporate-income surtax extension decision	Weekly	The exceptional corporate-income surtax costs Safran roughly $550M in FY26 cash. Legislated as 2024-2026 only — extension to 2027 hardens a structural ~$590M annual cash-flow tax that GE Aerospace, RTX, and Honeywell do not carry, and converts the bear case from "timing-driven" to "structurally lower run-rate".	French government 2027 budget text, Bercy press, draft amendments in the Assemblee Nationale and Senat, Conseil Constitutionnel decisions, and Safran management commentary at results, CMD, or AGM quantifying the FY27 cash impact.

Why These Five

The report's open questions distill to one near-term cash-quality test, one binary governance tail, one binary long-duration moat test, and two structural compounding inputs.

• Monitor 1 is the only watch item that resolves the single tension on which Verdict's "Lean Long, Wait For Confirmation" rests — whether the FY25 $1.2B working-capital tailwind reverses cleanly or normalizes downward. It is deliberately framed around the durable 65-75% conversion ratio, not the late-July H1 print alone, because the variant tab's most defensible disagreement with consensus is that this is a multi-year question, not a one-event question.
• Monitor 2 addresses the single non-financial issue that could re-rate the Equipment & Defense compounding case independent of operating results. The Pentagon's disposition of the 20 March Moolenaar letter is binary and slow-moving; absence-of-update through Q3 effectively closes the issue for the underwriting window, but a procurement restriction would force a structural reset.
• Monitor 3 is the only watch tied directly to the failure mode rated existential to the wide-moat rating beyond 2035. The catalyst window is long (airframer commitment 2027-2030, EIS ~2035), but the demonstrator and architecture-study disclosures arrive continuously and asymmetrically. A CFM win re-extends the property right by 30 years; a loss starts the fade clock.
• Monitor 4 is the most reliable forward proxy for LEAP installed-base growth, which is the engine of the aftermarket compounding driver. GTF rework completion is the cyclical recapture risk; LEAP-1B blade durability is the operational durability test.
• Monitor 5 is the cleanest test of whether the structural cost drags bear flagged stay bounded or widen. The 2027 budget decision is calendared (Sep-Dec 2026), durable in scope (multi-year cash impact), and asymmetric (extension hurts more than sunset helps because management already guides FY26 with the hit in).

Items deliberately excluded: a generic "next earnings" monitor (Monitor 1 carries the thesis variable that the earnings print tests), a buyback-execution monitor (already in disclosure and not thesis-changing on a margin basis), an EUR-USD hedge-book monitor (covered through 2028; only matters when hedges roll), and a peer-multiple GE Aerospace comp monitor (covered by quarterly results not continuous web evidence).

---

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Where We Disagree With the Market

The market has compressed the Safran debate into a single decisive event — the 28 July H1-2026 receivables print — and treats the answer as binary. We disagree on the framing more than on the facts. The durable variable is the cash-conversion ratio of the aftermarket annuity across a multi-year window, not the one-period reversal of a $1.2B working-capital tailwind. The same compression shows up in three other places: consensus increasingly anchors valuation at the peer-median ex-GE (~13× EV/EBITDA), treating the gap to GE Aerospace at 33.9× as a US-listing artefact rather than as the credible cash-flow anchor that the contractual JV identity implies; consensus celebrates +26% Recurring ROCI growth as the compounding rate when the metric flowing to owners (adjusted profit attributable) grew just +3.5% in FY25; and consensus prices neither outcome of the CFM RISE / next-narrowbody architecture decision in 2027–2030, the single binary that sets the wide-moat rating beyond 2035. None of these are contrarian for performance — each is a place where the report's own evidence contradicts a specific market belief and where the disagreement resolves on observable signals.

Variant Perception Scorecard

A score of 55 reads as a genuine but nuanced edge, not a screaming mispricing. The consensus is clear (sell-side mean target $400 from 22 analysts on Moderate-Buy, the stock at 20.3× FY25 EV/EBITDA, debate framed around the late-July H1 print). The evidence supporting the variant views is strong but interpretive — the upstream tabs document the data, but the variant claims rest on how one weighs Recurring ROCI versus Adjusted EPS, the GE multiple versus the ex-GE median, and one print versus a 3-year window. Resolution mostly runs on a 12–24 month clock through the FY26 cumulative cash-conversion print, sell-side estimate revisions, and the architecture-decision flow on RISE.

Consensus Map

Consensus is most clearly observable on issues 1–3 — each has a direct sell-side, management, or price-level signal behind it. Issues 4 and 5 are inferences from price action and sell-side framing rather than explicit consensus statements, and the variant edge is correspondingly thinner. Issue 6 is sentiment-level, not analytical.

The Disagreement Ledger

Disagreement 1 — H1-26 is necessary but not sufficient. A consensus analyst would say: the late-July H1 print resolves the working-capital question, the multiple re-rates, the stock either trades to $400 (consensus target) on a clean reversal or compresses to $274-$285 on a miss. Our evidence disagrees because the upstream forensic tab is explicit that the conversion-ratio question requires a multi-year window: the 3-year FCF-after-M&A / Net Income ratio of 0.94 already trails the 1.17 ex-M&A read, and management's own 2028 ambition is built on cumulative 4-year conversion. If we are right, the market would have to concede that the H1 print is a noisy first reading, not the answer, and that the multiple should be set against a 3-year cumulative window. The cleanest disconfirming signal is a clean H1-26 reversal followed by normalized supplier-finance disclosure and a 2026 FCF print at the upper end of guide, two readings in the same direction — at that point the variant view ages out.

Disagreement 2 — GE is the right anchor. A consensus analyst would say: GE trades at 33.9× because of cleaner US reporting, no IFRS hedge mark-to-market noise, and structural US-listing premium; the right Safran multiple is the European peer median (~13–17×), and at 20.3× the stock is already at the top of that range. Our evidence disagrees because Safran and GE own 50% of the same CFM cash-flow stream by contract through 2050, and the underlying property right is identical — type-certificate-protected aftermarket on the LEAP and CFM56 installed base. The accounting and listing differences justify a multi-turn discount, not a 14-turn gap. If we are right, the market would have to concede that the JV cash-flow identity is the credible anchor and the peer-median ex-GE is the wrong comp set, which closes roughly half the gap (Safran toward 27× rather than peer-median 13×). The cleanest disconfirming signal is GE-Safran segment cash diverging through FY26-27 — if GE Aerospace cash grows materially faster than Safran Propulsion cash on the same JV, the property-right identity claim is weaker than we think.

Disagreement 3 — +3.5% is the rate flowing to owners, not +26%. A consensus analyst would say: the +26% Recurring ROCI growth is the compounding rate, the +3.5% adjusted profit number is depressed by one-time portfolio cleanup (SPI, Interiors), and the right normalized rate sits somewhere in between but closer to the recurring metric. Our evidence disagrees because the $497M Interiors impairment and $(287)M SPI capital loss represent real capital that was deployed (Zodiac 2018, $10.0B) and is now being written down — and there may be more (up to $1.76B Interiors review still open). The pattern of recurring "non-recurring" items above 1.5% of revenue is itself the forensic signal. If we are right, the market would have to concede that the rate at which Safran compounds owner capital is closer to +3.5–8% than to +26%, which implies a sustainable P/E closer to 17–20× than 30–35×. The cleanest disconfirming signal is a clean FY26 (and FY27) with no further excluded-loss items and Recurring ROCI / Adjusted EPS growth converging within 500bps.

Disagreement 4 — RISE is binary and existential, not deferrable. A consensus analyst would say: the architecture decision is 4–6 years out, the demonstrator is still in development, and the market values the franchise on the current LEAP installed base and the 2028 ambition. Our evidence disagrees because every upstream tab (Long-Term Thesis, Moat, Business) names RISE as the single existential moat variable beyond 2035. Pricing the franchise as if RISE is automatic (or as if a RISE loss has no impact) is internally inconsistent — both bull and bear cases implicitly assume RISE wins. If we are right, the market would have to concede that a probability-weighted RISE outcome implies a 5–15% expected-value haircut to fair value today, even at a high P(RISE wins). The cleanest disconfirming signal is an Airbus / Boeing public commitment to open-fan architecture or a CFM-named launch propulsion partner announcement before 2028, which collapses the binary to ~certainty.

Evidence That Changes the Odds

The most decision-relevant rows are #1 (the working-capital question is structurally multi-year, not single-print), #2 (the GE/Safran multiple gap is the cleanest mispricing signal in the entire deck), and #3 (the wedge between Recurring ROCI and Adjusted EPS is what the multiple is ignoring). Rows #4 and #6 are the live pipeline of evidence that strengthens or weakens disagreements #3 and the structural-drag thesis. Row #5 is the binary the market is not pricing; row #7 sets a fair boundary on disagreement #3 by acknowledging that the adjusted-EPS frame correctly excludes the non-cash hedge MTM.

How This Gets Resolved

Five of these six signals run on a 12–36 month clock — the variant framing is genuinely multi-year, not a next-quarter call. Signal #1 (cash conversion) provides interim reads on a 6-month cadence starting with the late-July 2026 H1 print, but the decisive cumulative read is FY28. Signal #2 (GE-Safran gap) reads in real time but the durable test is whether the gap compresses on consistent estimates over 12+ months, not on any single quarter. Signal #4 (RISE) is the longest-dated and the most binary; signal #5 (surtax) is the cleanest near-term test of the structural-cost-drag thesis.

What Would Make Us Wrong

The strongest disconfirming case is straightforward: a clean H1-2026 receivables print with DSO retracing below 145 days, supplier-finance disclosed under $590M, FY26 FCF landing in the upper half of guide, and the wedge between Recurring ROCI and Adjusted EPS narrowing to under 500bps as no further Interiors impairment lands — all in the same 18 months. In that world the market's compressed framing turns out to be correct: the H1 print did resolve the question, the FY25 working-capital stretch was timing, and the +26% Recurring ROCI was the right compounding rate because there is no further excluded-loss residue. Disagreement #1 ages out cleanly; disagreement #3 weakens to a footnote. The variant view that the market's framing is too compressed loses both its empirical and its conceptual edge.

The GE-anchor variant (disagreement #2) is the most vulnerable to a specific kind of fact pattern. If through FY26-27 GE Aerospace's segment cash grows materially faster than Safran's Propulsion segment cash, the contractual JV identity claim is weaker than we are stating — the same property right is producing materially different cash for the two partners, which would imply the gap reflects real economic substance rather than listing-and-accounting penalty. The data exists to test this; both companies disclose the relevant segment numbers quarterly. We should be honest that we have only the FY25 snapshot today and the through-cycle test is ahead of us.

Disagreement #4 (RISE) is the hardest to "be wrong about" in the near term because resolution is 2027–2030, but the symmetric risk is real. If the architecture-decision question itself never gets sharper — if Airbus and Boeing remain non-committal into the late 2020s — then a probability-weighted RISE adjustment to fair value today is largely academic for any underwriting horizon under 5 years. The variant view holds intellectually but stops being decision-useful, which is a soft form of being wrong.

The other place we could be wrong is more general: the consensus is not as compressed as we read it. Stan's verdict itself, in a sense, is already a variant view — "lean long, wait for confirmation" is not the consensus framing of "buy on the print." If institutional consensus is actually more nuanced than the sell-side preview anchoring suggests, then several of our disagreements are differences of degree, not of kind, and the variant strength score of 55 is itself too high.

The first thing to watch is the late-July 2026 H1-2026 receivables and contract-asset disclosure — not because it resolves the variant view (it does not), but because it is the next observable update to whichever side of disagreement #1 holds, and because the way the market reacts to it will reveal how compressed the consensus framing actually is.

---

Liquidity & Technical

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, technical indicators (RSI, MACD, realized volatility), share counts, and percentages are unitless and unchanged.

Safran trades $213M per day on Euronext Paris — institutional-grade liquidity for any fund up to roughly $4.4B AUM building a 5% position in five sessions. The tape is the constraint, not the order book: a death cross on 8 May 2026 left price marginally below the 200-day, momentum has bounced but volume has not confirmed, and realized volatility sits in the stressed regime above the 10-year 80th percentile.

1. Portfolio implementation verdict

2. Price snapshot

3. Price + 50/200-day moving averages — 10-year view

Price is below the 200-day SMA ($347.45 vs $349.02, –0.4%). The 50-day at $335.64 sits below the 200-day at $349.02. Stepping back, the 10-year arc is a clean uptrend ($70 → $400 ATH in February 2026), but the last four months show a rounded top: a 19% drawdown from the February ATH to the April low, a bounce, and a stall right at the 200-day. This is a transitional regime — not a confirmed downtrend, but no longer the runaway 2024–2025 uptrend.

4. Relative strength

Local-currency benchmark data was unavailable for this run (no European broad-market or aerospace-sector ETF series staged in data/tech/relative_performance.json). A relative-strength chart against the cross-border SPY benchmark would conflate FX moves with operating outperformance and is omitted rather than fabricated.

For reader context, the absolute return profile from data/tech/momentum.json is:

The shape — strong 3y/5y, weak 3-month — is the classic profile of a multi-year winner pausing. Whether this resolves up or down is what the next two sections address.

5. Momentum — RSI and MACD (18 months, weekly close)

RSI sits at 54.7 — neutral, not yet stretched. The 5–7 week sequence is interesting: a punch to 29.9 oversold in early April (capitulation low at $318), a sharp recovery through 70 in late May, and a pullback to 54.7 last week. That recovery from oversold without retesting the low is constructive, but the failure to hold above 70 also says the bounce has lost intensity. MACD histogram crossed back positive on 15 May 2026, peaked at +3.2 on 22 May, and has rolled over to +1.3 — a textbook fading bullish impulse, not a clean continuation signal.

6. Volume, volatility, and sponsorship

Five of the top ten volume spikes since 2016 were down days. Heavy volume on declines is the pattern: distribution, not accumulation. The most recent spike on 20 March 2026 (3.2× average, –4.0%) sits inside the February–April correction. By contrast, the recent bounce from $318 to $356 happened on average volume — buyers, but not aggressive ones.

Realized 30-day vol is 41.5% — above the 80th-percentile band of 33%, in the stressed regime. The last time vol stayed this elevated for multiple months was the March–May 2025 dislocation (peak 64.9%). A wider risk premium is being demanded; option-implied costs and intraday gap risk are above normal for this name.

7. Institutional liquidity panel

The 20-day ADV ($212M) is roughly 19% below the 60-day ADV ($260M), confirming that participation has thinned during the recent correction. Annual turnover of 33% is below the typical European mega-cap range (40–60%) — Safran's free float is well-held by long-term sponsors, which limits both upside acceleration on flows and downside cascade risk on outflows.

Fund-capacity table

Liquidation runway

Median 60-day daily range is 1.04% — tight intraday, well below the 2% threshold where market-impact costs become problematic for large orders. Zero zero-volume days in the last 60 sessions.

Practical sizing read. At 20% ADV, the largest position that clears in five sessions is roughly $218M (about 0.15% of market cap); at 10% ADV, $109M. A $6B fund can fully build a 5% position ($300M) inside seven trading sessions at 20% ADV. A $30B fund attempting the same 5% weight ($1.5B) needs 35+ sessions and meaningful TWAP discipline — and is the practical capacity ceiling. Above $60B AUM at 5% target weight, Safran is a "scale in over a quarter" name, not a tactical one.

8. Technical scorecard + stance

Stance: NEUTRAL with bearish lean on a 3–6 month horizon, net score −1. The dominant signal is the death cross plus stressed volatility plus weakening volume on the bounce — a pattern that historically resolves with at least a re-test of the recent low before resuming the secular uptrend. Two levels frame the decision: a close above $361 (Bollinger upper, reclaim of 100-day at $352 and 200-day at $349, marking a successful retest) flips the setup back to constructive and confirms that the April low was the corrective bottom; a close below $312 (Bollinger lower) opens the path to the 52-week low at $293 and signals that the death cross is operative, not noise. Liquidity is not the constraint for any fund under roughly $6B AUM at a 5% target weight — for larger pools, build slowly over multiple weeks at 10–15% participation. For everyone else, the correct action is to wait: watchlist with alerts at $361 (add) and $312 (avoid / lighten existing).

---

Short Interest & Thesis

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates (period-end EUR/USD 2024-12-31 1.0389; 2025-12-31 1.1750; 2026-06-08 1.1640). Ratios, margins, multiples, share counts, dates and names are unitless and unchanged.

Short interest is not decision-useful for the primary ENXTPA:SAF listing. No deterministic reported-short-interest fetcher is configured for the French market in this run, and the AMF/EU Short Selling Regulation public threshold (≥0.5% of share capital, ≈2.09 M shares) shows no disclosed net short positions for Safran in the period reviewed. The only hard, source-labeled positioning data comes from the OTC ADR SAFRY — a peripheral listing with single-digit-thousand-share movements that confirms there is no aggressive shorting at the ADR level but cannot be extrapolated to the underlying Euronext free float. There is no active short-seller campaign, activist short, or unresolved accounting allegation identified; the only unresolved bear case is the receivables/DPO timing flag already documented in the forensic tab.

1. KPI strip

The SAFRY days-to-cover and the AMF nil-disclosure together rule out a crowded-short setup; the forensic score is referenced from the dedicated tab and is the real position-sizing input here.

2. Data availability

This page must be read knowing what is missing as much as what is present.

3. SAFRY ADR short interest — the only hard time series

The only public, source-labeled positioning data is for the OTC ADR SAFRY (Pink Sheets, US7865841024). It tracks short interest in a peripheral listing whose typical absolute level is in the tens-of-thousands of shares — i.e. a fraction of one percent of underlying economic exposure on the Paris float. The series is useful for one purpose only: confirming that no positioning bubble exists at the ADR level. It cannot be extrapolated to the ENXTPA primary tape.

A single spike to 366k ADR shares on 31-Mar-26 (0.55 days-to-cover) inside the broader Feb-Apr 2026 correction stands out; it unwound 75% by 15-Apr-26 to 91k shares (0.1 days). Even at the local peak, days-to-cover stayed below 0.6 — the ADR was never crowded. Bi-weekly reporting volatility is high but the level signal is consistently negligible.

4. AMF / EU SSR disclosure regime

The AMF publishes net short positions equal to or higher than 0.5% of share capital under EU Regulation 236/2012 via the BDIF database and a daily NSP file on data.gouv.fr. For Safran (417.88 M shares outstanding), the 0.5% threshold corresponds to ≈2,089,415 shares, equivalent to roughly 3.3 trading days at the 20-day ADV of 627k shares.

Two cautions are needed. First, the AMF regime captures only public disclosures above 0.5%; positions between 0.2–0.5% are reported privately to the regulator and do not appear in the BDIF. Second, the absence of public disclosures means no single holder is large and persistent enough to disclose — it does not mean aggregate short interest is zero. The aggregate could still be 1–2% of float, distributed across many sub-threshold holders, without any visible AMF footprint. The honest read is: there is no evidence of a concentrated, decision-relevant short position, and no evidence of one either way for diffuse positioning.

5. Short-thesis ledger

A separate question from positioning is the quality of the bear case. The standard test: are there credible reports, forensic allegations, or unresolved regulatory issues that warrant a structural short? The evidence below separates active credible thesis material from public bear opinion from dormant historical episodes.

The substantive bear case lives at row 2 — the working-capital timing question carried over from the forensic tab. Until the H1-2026 receivables print quantifies how much of the FY25 ~$4.6B receivables build was Rafale/state-customer timing versus pulled-forward revenue, there is an unresolved cash-quality argument that a short might press. No public short-seller has pressed it.

6. Borrow / securities-lending pressure

Hard borrow data is not staged for either listing. The only public signal is a single Investing.com syndication of a Benzinga "Short Volatility Alert" referencing a securities-lending volatility indicator firing on SAF — undated in the source, no quantitative borrow fee, utilization, lendable supply, or rebate-rate figure attached, and not corroborated by a second source. We log it for completeness but do not treat it as decision-useful.

In the absence of staged borrow-fee or utilization data, the institutional read is: Safran is well-sponsored, low-turnover, and shows no public sign of borrow scarcity. A locate friction at scale would have surfaced in the AMF disclosures by now if it existed.

7. Crowding vs liquidity — reference framework

Without an aggregate short-interest figure, we cannot say what days-to-cover would actually be. The table below gives the threshold scenarios so any future data point can be sized immediately.

ADV is 627,139 shares / day (20-day); market cap ~$145.1B; float ~345.8M shares per TradingView. At 33% annual turnover Safran sits below the typical European mega-cap range — which means modest short exposure can take longer to cover than the days-to-cover math suggests on a normal-market day. Even so, in the absence of any public position, there is no crowding case to make.

8. Market setup — does positioning change the catalyst read?

The implication for sizing: shorting interest does not push us either way on entry timing. The PM input that matters here is the forensic-tab conclusion (size on adjusted EPS ~$8.85 and steady-state FCF ~$3.3–3.5B), not the short tape.

9. Evidence quality

10. What to monitor

Three concrete watch items. Order matters.

1. H1-2026 receivables print (expected late Jul-26). The only credible short angle on Safran is the WC/DPO question carried in the forensic tab. Until that resolves, any new public short report should be assumed to be pressing this issue and read against the prior. A clean reversal closes the bear case; a flat or widening receivables-vs-revenue gap could attract a forensic-style note.

2. AMF BDIF / data.gouv.fr daily NSP file. A first-time crossing of the 0.5% threshold by any single holder would be the single most decision-useful data point this tab can deliver in real time. The file is daily; set an alert on "Safran SA" or "FR0000073272" entries.

3. SAFRY ADR semi-monthly print (next 15-May-26 / 31-May-26). The 31-Mar-26 spike (366k ADR shares, 0.55 days-to-cover) was the largest in the series. A repeat spike alongside an AMF disclosure or a published short report would warrant re-reading this tab; a continued sub-100k baseline confirms no positioning bubble.

Bottom line

There is no decision-useful short-interest signal in Safran today. The right institutional read is: positioning is a null input for sizing and timing, and the meaningful unresolved bear argument is the receivables/DPO question already documented one tab over. If a credible short report appears between now and the H1-26 print, re-open this page.